JELD-WEN Holding (JELD) 10-Q 6 Nov 24 2024 Q3 Quarterly report Financial data

Cover

Cover - shares	9 Months Ended
	Sep. 28, 2024	Nov. 01, 2024
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Sep. 28, 2024
Document Transition Report	false
Entity File Number	001-38000
Entity Registrant Name	JELD-WEN Holding, Inc.
Entity Incorporation, State	DE
Entity Tax Identification Number	93-1273278
Entity Address, Street Name	2645 Silver Crescent Drive
Entity Address, City	Charlotte
Entity Address, State	NC
Entity Address, Postal Zip Code	28273
City Area Code	704
Local Phone Number	378-5700
Title of each class	Common Stock (par value $0.01 per share)
Trading Symbol	JELD
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		84,619,663
Entity Central Index Key	0001674335
Amendment Flag	false
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q3
Current Fiscal Year End Date	--12-31

CONSOLIDATED STATEMENTS OF OPER

CONSOLIDATED STATEMENTS OF OPERATIONS (unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 28, 2024	Sep. 30, 2023	Sep. 28, 2024	Sep. 30, 2023
Income Statement [Abstract]
Net revenues	$ 934,716	$ 1,076,980	$ 2,879,858	$ 3,283,269
Cost of sales	754,845	853,384	2,337,362	2,642,331
Gross margin	179,871	223,596	542,496	640,938
Selling, general and administrative	143,294	162,820	494,548	478,060
Goodwill impairment (Note 6)	63,445	0	63,445	0
Restructuring and asset-related charges (Note 16)	25,540	12,698	60,046	28,776
Operating income (loss)	(52,408)	48,078	(75,543)	134,102
Interest expense, net	16,319	16,737	48,575	59,083
Loss on extinguishment and refinancing of debt (Note 10)	459	6,487	1,908	6,487
Other income, net (Note 18)	(3,475)	(9,453)	(20,226)	(10,981)
(Loss) income from continuing operations before taxes	(65,711)	34,307	(105,800)	79,513
Income tax expense (Note 11)	7,251	17,399	13,383	31,638
(Loss) income from continuing operations, net of tax	(72,962)	16,908	(119,183)	47,875
(Loss) gain on sale of discontinued operations, net of tax (Note 2)	(1,440)	26,076	(1,440)	26,076
Income from discontinued operations, net of tax (Note 2)	0	801	0	23,249
Net (loss) income	$ (74,402)	$ 43,785	$ (120,623)	$ 97,200
Weighted average common shares outstanding (Note 14):
Basic (in shares)	84,554,174	85,182,678	85,115,070	84,915,519
Diluted (in shares)	84,554,174	86,349,840	85,115,070	85,729,136
Net (loss) income per share from continuing operations
Basic (usd per share)	$ (0.86)	$ 0.20	$ (1.40)	$ 0.56
Diluted (usd per share)	(0.86)	0.20	(1.40)	0.56
Net (loss) income per share from discontinued operations
Basic (usd per share)	(0.02)	0.32	(0.02)	0.58
Diluted (usd per share)	(0.02)	0.31	(0.02)	0.58
Net (loss) income per share
Basic (usd per share)	(0.88)	0.51	(1.42)	1.14
Diluted (usd per share)	$ (0.88)	$ 0.51	$ (1.42)	$ 1.13

CONSOLIDATED STATEMENTS OF COMP

CONSOLIDATED STATEMENTS OF COMPREHENSIVE (LOSS) INCOME (unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 28, 2024	Sep. 30, 2023	Sep. 28, 2024	Sep. 30, 2023
Statement of Comprehensive Income [Abstract]
Net (loss) income	$ (74,402)	$ 43,785	$ (120,623)	$ 97,200
Other comprehensive income (loss), net of tax:
Foreign currency translation adjustments, net of tax (benefit) expense of $(109), $1,200, $1,096 and $2,353, respectively.	23,246	12,418	1,004	12,097
Net investment hedge adjustments, net of tax benefit $854 during the three months ended September 30, 2023.	0	(2,511)	0	0
Interest rate hedge adjustments, net of tax benefit of $327, $1,115, $217 and $2,939, respectively.	(971)	(3,365)	(645)	(8,726)
Defined benefit pension plans, net of tax (benefit) expense of $(18), $451, $(8) and $487, respectively.	(62)	1,169	(32)	1,265
Total other comprehensive income, net of tax	22,213	7,711	327	4,636
Comprehensive (loss) income	$ (52,189)	$ 51,496	$ (120,296)	$ 101,836

CONSOLIDATED STATEMENTS OF CO_2

CONSOLIDATED STATEMENTS OF COMPREHENSIVE (LOSS) INCOME (unaudited) (Parenthetical) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 28, 2024	Sep. 30, 2023	Sep. 28, 2024	Sep. 30, 2023
Statement of Comprehensive Income [Abstract]
Foreign currency translation adjustments, net of tax (benefit) expense	$ (109)	$ 1,200	$ 2,353	$ 1,096
Net investment hedge adjustments, net of tax (benefit) expense		(854)
Interest rate hedge adjustments, net of tax expense (benefit)	(327)	(1,115)	(217)	(2,939)
Defined benefit pension plans, net of tax (benefit) expense	$ (18)	$ 451	$ (8)	$ 487

CONSOLIDATED BALANCE SHEETS (un

CONSOLIDATED BALANCE SHEETS (unaudited) - USD ($) $ in Thousands	Sep. 28, 2024	Dec. 31, 2023
Current assets
Cash and cash equivalents	$ 208,500	$ 288,312
Restricted cash	814	835
Accounts receivable, net (Note 3)	491,910	516,674
Inventories (Note 4)	481,676	481,451
Other current assets	75,187	71,507
Assets held for sale (Note 17)	148,733	135,563
Total current assets	1,406,820	1,494,342
Property and equipment, net (Note 5)	670,790	644,242
Deferred tax assets	155,519	150,453
Goodwill (Note 6)	326,406	390,170
Intangible assets, net (Note 7)	103,320	123,910
Operating lease assets, net	132,700	146,931
Other assets	39,165	30,077
Total assets	2,834,720	2,980,125
Current liabilities
Accounts payable	318,862	269,322
Accrued payroll and benefits	81,790	132,550
Accrued expenses and other current liabilities (Note 8)	253,127	233,796
Current maturities of long-term debt (Note 10)	30,854	36,177
Liabilities held for sale (Note 17)	9,287	7,064
Total current liabilities	693,920	678,909
Long-term debt (Note 10)	1,179,883	1,190,075
Unfunded pension liability	27,868	26,502
Operating lease liability	108,046	121,993
Deferred credits and other liabilities	98,465	104,831
Deferred tax liabilities	6,248	7,170
Total liabilities	2,114,430	2,129,480
Commitments and contingencies (Note 21)
Shareholders’ equity
Preferred Stock, par value $0.01 per share, 90,000,000 shares authorized; no shares issued and outstanding	0	0
Common Stock: 900,000,000 shares authorized, par value $0.01 per share, 84,617,518 and 85,309,220 shares issued and outstanding as of September 28, 2024, and December 31, 2023, respectively.	846	853
Additional paid-in capital	766,383	752,171
Retained earnings	48,044	192,931
Accumulated other comprehensive loss	(94,983)	(95,310)
Total shareholders’ equity	720,290	850,645
Total liabilities and shareholders’ equity	$ 2,834,720	$ 2,980,125

CONSOLIDATED BALANCE SHEETS (_2

CONSOLIDATED BALANCE SHEETS (unaudited) (Parenthetical) - $ / shares	Sep. 28, 2024	Dec. 31, 2023
Statement of Financial Position [Abstract]
Preferred stock, par value (usd per share)	$ 0.01	$ 0.01
Preferred stock, shares authorized (in shares)	90,000,000	90,000,000
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Common stock, shares authorized (in shares)	900,000,000	900,000,000
Common stock, par value (usd per share)	$ 0.01	$ 0.01
Common stock, shares issued (in shares)	84,617,518	85,309,220
Common stock, shares outstanding (in shares)		85,309,220

CONSOLIDATED STATEMENTS OF EQUI

CONSOLIDATED STATEMENTS OF EQUITY (unaudited) - USD ($) $ in Thousands	Total	Preferred stock	Common stock	Additional paid-in capital	Other additional paid in capital	Other additional paid in capital Employee stock notes	Retained earnings	Accumulated other comprehensive loss	Foreign currency adjustments	Unrealized loss on net investment hedges	Unrealized loss on interest rate hedges	Net actuarial pension (loss) gain
Balance at beginning of period (in shares) at Dec. 31, 2022		0
Balance at beginning of period at Dec. 31, 2022		$ 0	$ 843		$ 735,526	$ (673)	$ 130,486	$ (142,634)
Balance at beginning of period (in shares) at Dec. 31, 2022			84,347,712
Increase (Decrease) in Stockholders' Equity
Shares issued for exercise/vesting of share-based compensation awards (in shares)			975,200
Shares issued for exercise/vesting of share-based compensation awards			$ 10		221
Shares surrendered for tax obligations for employee share-based transactions (in shares)			(108,461)
Shares surrendered for tax obligations for employee share-based transactions			$ (1)		(1,637)
Amortization of share-based compensation					13,181
Net (loss) income	$ 97,200						97,200
Foreign currency adjustments	12,097								$ 12,097
Unrealized loss on interest rate hedges											$ (8,726)
Net actuarial pension (loss) gain	1,265											$ 1,265
Balance at end of period at Sep. 30, 2023	837,158		$ 852	$ 746,618	747,291	(673)	227,686	(137,998)
Balance at period end (in shares) at Sep. 30, 2023			85,214,451
Balance at beginning of period (in shares) at Jul. 01, 2023		0
Balance at beginning of period at Jul. 01, 2023		$ 0	$ 850		744,015	(673)	183,901	(145,709)
Balance at beginning of period (in shares) at Jul. 01, 2023			85,048,937
Increase (Decrease) in Stockholders' Equity
Shares issued for exercise/vesting of share-based compensation awards (in shares)			182,966
Shares issued for exercise/vesting of share-based compensation awards			$ 2		86
Shares surrendered for tax obligations for employee share-based transactions (in shares)			(17,452)
Shares surrendered for tax obligations for employee share-based transactions					(306)
Amortization of share-based compensation					3,496
Net (loss) income	43,785						43,785
Foreign currency adjustments	12,418								12,418
Unrealized loss on net investment hedges										$ (2,511)
Unrealized loss on interest rate hedges											(3,365)
Net actuarial pension (loss) gain	1,169											1,169
Balance at end of period at Sep. 30, 2023	$ 837,158		$ 852	746,618	747,291	(673)	227,686	(137,998)
Balance at period end (in shares) at Sep. 30, 2023			85,214,451
Balance at beginning of period (in shares) at Dec. 31, 2023	0	0
Balance at beginning of period at Dec. 31, 2023	$ 850,645	$ 0	$ 853		752,844	(673)	192,931	(95,310)
Balance at beginning of period (in shares) at Dec. 31, 2023	85,309,220		85,309,220
Increase (Decrease) in Stockholders' Equity
Shares issued for exercise/vesting of share-based compensation awards (in shares)			976,260
Shares issued for exercise/vesting of share-based compensation awards			$ 10		2,866
Shares repurchased (in shares)	(1,600,000)		(1,600,000)
Shares repurchased			$ (16)				(24,264)
Shares surrendered for tax obligations for employee share-based transactions (in shares)			(67,962)
Shares surrendered for tax obligations for employee share-based transactions			$ (1)		(1,246)
Amortization of share-based compensation					12,592
Net (loss) income	$ (120,623)						(120,623)
Foreign currency adjustments	1,004								1,004
Unrealized loss on interest rate hedges											(645)
Net actuarial pension (loss) gain	$ (32)											(32)
Balance at period end (in shares) at Sep. 28, 2024	0
Balance at end of period at Sep. 28, 2024	$ 720,290		$ 846	766,383	767,056	(673)	48,044	(94,983)
Balance at period end (in shares) at Sep. 28, 2024			84,617,518
Balance at beginning of period (in shares) at Jun. 29, 2024		0
Balance at beginning of period at Jun. 29, 2024		$ 0	$ 845		764,603	(673)	122,446	(117,196)
Balance at beginning of period (in shares) at Jun. 29, 2024			84,511,647
Increase (Decrease) in Stockholders' Equity
Shares issued for exercise/vesting of share-based compensation awards (in shares)			129,761
Shares issued for exercise/vesting of share-based compensation awards			$ 1		375
Shares repurchased (in shares)	(1,600,000)
Shares surrendered for tax obligations for employee share-based transactions (in shares)			(23,890)
Shares surrendered for tax obligations for employee share-based transactions					(381)
Amortization of share-based compensation					2,459
Net (loss) income	$ (74,402)						(74,402)
Foreign currency adjustments	23,246								$ 23,246
Unrealized loss on interest rate hedges											$ (971)
Net actuarial pension (loss) gain	$ (62)											$ (62)
Balance at period end (in shares) at Sep. 28, 2024	0
Balance at end of period at Sep. 28, 2024	$ 720,290		$ 846	$ 766,383	$ 767,056	$ (673)	$ 48,044	$ (94,983)
Balance at period end (in shares) at Sep. 28, 2024			84,617,518

CONSOLIDATED STATEMENTS OF EQ_2

CONSOLIDATED STATEMENTS OF EQUITY (unaudited) (Parenthetical) - $ / shares	Sep. 28, 2024	Dec. 31, 2023	Sep. 30, 2023
Statement of Stockholders' Equity [Abstract]
Preferred stock, par value (usd per share)	$ 0.01	$ 0.01	$ 0.01
Common stock, par value (usd per share)	$ 0.01	$ 0.01	$ 0.01

CONSOLIDATED STATEMENTS OF CASH

CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited) - USD ($) $ in Thousands		9 Months Ended
		Sep. 28, 2024	Sep. 30, 2023
OPERATING ACTIVITIES
Net (loss) income		$ (120,623)	$ 97,200
Adjustments to reconcile net income to cash provided by (used in) operating activities:
Depreciation and amortization		97,552	102,704
Deferred income taxes		(9,695)	8,817
Net gain on sale of business, property and equipment		(8,176)	(3,906)
Goodwill impairment		63,445	0
Adjustment to carrying value of assets		18,002	4,759
Amortization of deferred financing costs		1,870	2,148
Loss on extinguishment and refinancing of debt		1,246	6,487
Loss on foreign currency translation adjustment related to the substantial liquidation of a foreign subsidiary		4,290	0
Loss (gain) on sale of discontinued operations, net of tax		1,440	(26,076)
Share-based compensation expense		12,592	13,181
Amortization of U.S. pension expense		0	375
Recovery of cost from receipts on impaired notes		(1,389)	(3,000)
Other items, net		(5,189)	(10,684)
Net change in operating assets and liabilities:
Accounts receivable		20,399	(50,234)
Inventories		(1,394)	74,772
Other assets		(833)	22,105
Accounts payable and accrued expenses		11,008	45,548
Change in short-term and long-term tax liabilities		(6,520)	(11,213)
Net cash provided by operating activities		78,025	272,983
INVESTING ACTIVITIES
Purchases of property and equipment		(109,806)	(69,627)
Proceeds from sale of business, property and equipment		11,661	6,259
Purchase of intangible assets		(8,213)	(10,734)
Proceeds (payments) related to the sale of JW Australia	[1]	0	367,525
Recovery of cost from receipts on impaired notes		1,389	3,000
Cash received for notes receivable		31	148
Cash received from insurance proceeds		1,655	3,165
Purchase of securities for deferred compensation plan		(3,113)	(893)
Net cash (used in) provided by investing activities		(106,396)	298,843
FINANCING ACTIVITIES
Change in long-term debt and payments of debt extinguishment costs		(25,595)	(549,346)
Common stock issued for exercise of options		2,876	231
Common stock repurchased		(24,280)	0
Payments to tax authorities for employee share-based compensation		(1,247)	(1,638)
Payments related to the sale of JW Australia		(2,037)	0
Net cash used in financing activities		(50,283)	(550,753)
Effect of foreign currency exchange rates on cash		(1,179)	(2,035)
Net (decrease) increase in cash and cash equivalents		(79,833)	19,038
Cash, cash equivalents and restricted cash, beginning		289,147	220,868
Cash, cash equivalents and restricted cash, ending		$ 209,314	$ 239,906
[1] (1) Includes proceeds from the sale of JW Australia, net of the $73.9 million of cash divested.

CONSOLIDATED STATEMENTS OF CA_2

CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical) $ in Thousands	Jul. 02, 2023 USD ($)
Held-for-sale | JW Australia
Disposal Group, Including Discontinued Operation, Cash and Cash Equivalents	$ 73,900

Description of Company and Summ

Description of Company and Summary of Significant Accounting Policies	9 Months Ended
	Sep. 28, 2024
Accounting Policies [Abstract]
Description of Company and Summary of Significant Accounting Policies	Description of Company and Summary of Significant Accounting Policies Nature of Business – JELD-WEN Holding, Inc., along with its subsidiaries, is a vertically integrated global manufacturer and distributor of windows, doors, and other building products that derives substantially all its revenues from the sale of its door and window products. Unless otherwise specified or the context otherwise requires, all references in these notes to “JELD-WEN,” “we,” “us,” “our,” or the “Company” are to JELD-WEN Holding, Inc. and its subsidiaries. Our continuing operations include facilities located in the U.S., Canada, and Europe. Our products are marketed primarily under the JELD-WEN brand name in the U.S. and Canada and under JELD-WEN and a variety of acquired brand names in Europe. Our revenues are affected by the level of new housing starts, residential and non-residential building construction, and repair and remodeling activity in each of our markets. Our sales typically follow seasonal new construction and repair and remodeling industry patterns. The peak season for home construction and remodeling in many of our markets generally corresponds with the second and third calendar quarters, and therefore, sales volume is typically higher during those quarters. Our first and fourth quarter sales volumes are generally lower due to reduced repair and remodeling activity and reduced activity in the building and construction industry as a result of colder and more inclement weather in certain areas of our geographic end markets. Basis of Presentation – The accompanying unaudited consolidated financial statements as of September 28, 2024 and for the three and nine months ended September 28, 2024 and September 30, 2023, respectively, have been prepared in accordance with GAAP for interim financial information and pursuant to the rules and regulations of the SEC. In the opinion of management, the unaudited consolidated financial statements have been prepared on the same basis as the audited financial statements and include all adjustments, consisting only of normal recurring adjustments, necessary for the fair statement of the Company’s financial position for the periods presented. The results for the three and nine months ended September 28, 2024 are not necessarily indicative of the results to be expected for the year ending December 31, 2024, or any other period. The accompanying consolidated balance sheet as of December 31, 2023 was derived from audited financial statements included in our Annual Report on Form 10-K. The accompanying consolidated financial statements do not include all of the information and footnotes required by GAAP for annual financial statements. Accordingly, they should be read in conjunction with the audited financial statements and notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2023. On April 17, 2023, we entered into a Share Sale Agreement with Aristotle Holding III Pty Limited, a subsidiary of Platinum Equity Advisors, LLC, to sell JW Australia. On July 2, 2023, we completed the sale. The net assets and operations of the disposal group met the criteria to be classified as “discontinued operations” and are reported as such in all periods presented unless otherwise noted. The consolidated statements of cash flows include cash flows from discontinued operations through the divestiture date of July 2, 2023. See Note 2 - Discontinued Operations for further information. All U.S. dollar and other currency amounts, except per share amounts, are presented in thousands unless otherwise noted. Fiscal Year – We operate on a fiscal calendar year, and each interim quarter is comprised of two 4-week periods and one 5-week period, with each week ending on a Saturday. Our fiscal year always begins on January 1 and ends on December 31. As a result, our first and fourth quarters may have more or fewer days included than a traditional 91-day fiscal quarter. Use of Estimates – The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates, assumptions, and allocations that affect amounts reported in the consolidated financial statements and related notes. Significant items that are subject to such estimates and assumptions include, but are not limited to, long-lived assets including goodwill and other intangible assets, employee benefit obligations, income tax uncertainties, contingent assets and liabilities, provisions for bad debt, inventory, warranty liabilities, legal claims, valuation of derivatives, environmental remediation, and claims relating to self-insurance. Actual results could differ due to the uncertainty inherent in the nature of these estimates. CARES Act – In March 2020, the United States government enacted the CARES Act to provide certain relief as a result of the COVID-19 pandemic. The CARES Act provided for tax relief, along with other stimulus measures, including a provision for an ERC designed to encourage businesses to retain employees during the COVID-19 pandemic. We recorded a receivable for an ERC from the U.S. government of $6.1 million in other income, net in the fourth quarter of 2023. The balance is included in other current assets in the accompanying consolidated balance sheets as of September 28, 2024 and December 31, 2023, respectively. Recent Accounting Standards Not Yet Adopted – In November 2023, the FASB issued ASU 2023-07, Improvements to Reportable Segment Disclosures . ASU 2023-07 requires disclosure of significant segment expenses that are regularly provided to the CODM and included within the segment measure of profit or loss, an amount and description of its composition for other segment items to reconcile to segment profit or loss, and the title and position of the entity’s CODM. ASU 2023-07 will be applied retrospectively and is effective for annual reporting periods in fiscal years beginning after December 15, 2023, and interim reporting periods in fiscal years beginning after December 31, 2024. We do not expect the guidance to have an impact on our financial positions and results of operations. We are currently evaluating the impact of this guidance on the Company’s disclosures. In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures . ASU 2023-09 expands disclosures in an entity’s income tax rate reconciliation table and regarding cash taxes paid both in the U.S. and foreign jurisdictions. The guidance is effective for annual periods beginning after December 15, 2024, with early adoption permitted, and should be applied either prospectively or retrospectively. We have not elected to early adopt this standard. We do not expect the guidance to have an impact on our financial positions and results of operations. We are currently evaluating the impact of this guidance on the Company’s disclosures. We have considered the applicability and impact of all ASUs. We have assessed ASUs not listed above and have determined that they were either not applicable or were not expected to have a material impact on our financial statements.

Discontinued Operations

Discontinued Operations	9 Months Ended
	Sep. 28, 2024
Discontinued Operations and Disposal Groups [Abstract]
Discontinued Operations	Discontinued Operations On April 17, 2023, we entered into a Share Sale Agreement with Aristotle Holding III Pty Limited, a subsidiary of Platinum Equity Advisors, LLC, to sell JW Australia, for a purchase price of approximately AUD $688 million. On July 2, 2023, we completed the sale, receiving net cash proceeds of approximately $446 million, including $3.3 million of cash received from the settlement of certain forward contracts. We have classified the results of operations for the JW Australia reportable segment, together with certain costs related to the sale, as discontinued operations within the consolidated statements of operations for all periods presented. Subsequent to the completion of the sale, we entered into an agreement to provide certain transition services to JW Australia, including providing information technology post-closing services, purchases under a supply agreement, and reimbursement for certain costs to upgrade specific IT systems up to a capped amount. As of September 28, 2024, we had a liability of $3.9 million relating to these matters, which was included in accrued expenses and other current liabilities in our consolidated balance sheet. As of December 31, 2023, our liability relating to these matters was $8.2 million, of which $6.1 million was included in accrued expenses and other current liabilities, and the remaining was included in deferred credits and other liabilities in the accompanying consolidated balance sheet. Components of amounts reflected in the consolidated statements of operations related to discontinued operations are presented in the table, as follows: Three Months Ended Nine Months Ended (amounts in thousands) September 30, 2023 September 30, 2023 Net revenues $ — $ 301,876 Cost of sales — 211,575 Gross margin — 90,301 Selling, general and administrative 606 62,083 Operating (loss) income (606) 28,218 Interest income, net — (685) Other income, net (17) (2,274) (Loss) income from discontinued operations before taxes (589) 31,177 Income tax (benefit) expense (1,390) 7,928 Income from discontinued operations, net of tax $ 801 $ 23,249 The cash flows related to discontinued operations have not been segregated and are included in the consolidated statements of cash flows through the divestiture date of July 2, 2023. The following table presents cash flow and non-cash information related to discontinued operations: Nine Months Ended (amounts in thousands) September 30, 2023 Depreciation and amortization $ 5,196 Capital expenditures 6,229 Share-based incentive compensation 812 Provision for bad debt 5,062 As of September 28, 2024 and December 31, 2023, the assets and liabilities associated with the court-ordered divestiture of Towanda as described further in Note 21 - C ommitments and Contingencies, qualify as held for sale. Since the Company will continue manufacturing door skins for its internal needs, the divestiture decision did not represent a strategic shift thereby precluding the divestiture as qualifying as a discontinued operation. In addition to the Towanda net assets, we own assets in Mexico, which are also classified as held for sale in the accompanying consolidated balance sheet as of September 28, 2024. Mexico had assets held for sale of $2.2 million at September 28, 2024. As of December 31, 2023, the assets and liabilities classified as held for sale are those of Towanda. As of September 28, 2024 and December 31, 2023, the related assets and liabilities included within the summary below were expected to be disposed of within the next twelve months and are included in assets held for sale and liabilities held for sale in the accompanying consolidated balance sheets. (amounts in thousands) September 28, 2024 December 31, 2023 Assets Inventories $ 16,322 $ 17,337 Other current assets 139 108 Property and equipment, net 63,385 50,672 Intangible assets, net 1,471 1,471 Goodwill 65,000 65,000 Operating lease assets, net 2,416 975 Assets held for sale $ 148,733 $ 135,563 Liabilities Accrued payroll and benefits $ 1,158 $ 901 Accrued expenses and other current liabilities 7,111 6,126 Operating lease liability 1,018 37 Liabilities held for sale $ 9,287 $ 7,064

Accounts Receivable

Accounts Receivable	9 Months Ended
	Sep. 28, 2024
Receivables [Abstract]
Accounts Receivable	Accounts Receivable We sell our manufactured products to a large number of customers, primarily in the residential housing construction and remodel sectors, broadly dispersed across many domestic and foreign geographic regions. We assess the credit risk relating to our accounts receivable based on quantitative and qualitative factors, including historical credit collections within each region where we have operations. We perform ongoing credit evaluations of our customers to minimize credit risk. We do not usually require collateral for accounts receivable, but do require advance payment, guarantees, a security interest in the products sold to a customer, and/or letters of credit in certain situations. Customer accounts receivable converted to notes receivable are collateralized by inventory or other collateral. At September 28, 2024 and December 31, 2023, we had an allowance for credit losses of $10.3 million and $11.3 million, respectively. The decrease in the allowance for credit losses in the nine months ended September 28, 2024 was primarily due to decreased sales and an improved portfolio of aged receivables in our North America segment.

Inventories

Inventories	9 Months Ended
	Sep. 28, 2024
Inventory Disclosure [Abstract]
Inventories	Inventories Inventories are stated at the lower of cost or net realizable value. Finished goods and work-in-process inventories include material, labor, and manufacturing overhead costs. (amounts in thousands) September 28, 2024 December 31, 2023 Raw materials $ 392,836 $ 404,360 Work in process 22,928 21,141 Finished goods 88,920 84,954 Inventory valuation reserves (23,008) (29,004) Total inventories $ 481,676 $ 481,451 To conform with current period presentation, certain amounts in prior period information have been reclassified.

Property and Equipment, Net

Property and Equipment, Net	9 Months Ended
	Sep. 28, 2024
Property, Plant and Equipment [Abstract]
Property and Equipment, Net	Property and Equipment, Net (amounts in thousands) September 28, 2024 December 31, 2023 Property and equipment $ 2,005,861 $ 1,966,371 Accumulated depreciation (1,335,071) (1,322,129) Total property and equipment, net $ 670,790 $ 644,242 We recorded accelerated depreciation of our plant and equipment of $7.9 million and $13.7 million during the three and nine months ended September 28, 2024, respectively, and $1.1 million and $4.3 million during the three and nine months ended September 30, 2023, respectively, within restructuring and asset-related charges in the accompanying consolidated statements of operations. For more information, refer to Note 16 - Restructuring and Asset-Related Charges. Additionally, we recorded accelerated depreciation of $9.1 million during the nine months ended September 30, 2023 from reviews of North America equipment capacity optimization, all of which were incurred in the second quarter. These charges were recorded within cost of sales in the accompanying consolidated statements of operations. The effect on our carrying value of property and equipment due to currency translations for foreign property and equipment, net, was an increase of $1.5 million as of September 28, 2024 compared to December 31, 2023, respectively. Depreciation expense was recorded as follows: Three Months Ended Nine Months Ended (amounts in thousands) September 28, 2024 September 30, 2023 September 28, 2024 September 30, 2023 Cost of sales $ 20,628 $ 19,315 $ 61,090 $ 69,843 Selling, general and administrative 1,192 1,379 3,440 4,267 Total depreciation expense $ 21,820 $ 20,694 $ 64,530 $ 74,110

Goodwill

Goodwill	9 Months Ended
	Sep. 28, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill	Goodwill Goodwill is tested for impairment on an annual basis during the fourth quarter and between annual tests if indicators of potential impairment exists. Between annual testing dates, the Company monitors factors such as its market capitalization, comparable company market multiples, macroeconomic conditions and individual reporting unit financial performance to identify conditions that could impact the Company’s assumptions utilized in the determination of the estimated fair values of the Company’s reporting units and indefinite-lived intangible assets significantly enough to trigger an impairment. The goodwill impairment tests are based on determining the fair value of the specified reporting units based on management judgments and assumptions using the discounted cash flows under the income approach classified in Level 3 of the fair value hierarchy and comparable company market valuation classified in Level 2 of the fair value hierarchy approaches. The valuation approaches are subject to key judgments and assumptions that are sensitive to change such as judgments and assumptions including revenue growth rates, expected EBITDA margins, market multiples, discount rates, capital expenditures and terminal growth rates. As previously disclosed, following our 2023 annual impairment test for our Europe reporting unit, we concluded that while no impairment existed, the fair value of our reporting unit exceeded its carrying value by approximately 3%. During the third quarter of 2024, the Company updated its financial forecast for the Europe reportable segment to reflect anticipated macroeconomic conditions of prolonged elevated interest rates leading to reduced revenue growth expectations. The end of the third fiscal quarter also marks the conclusion of our generally heavier seasonal sales period and our net sales were negatively impacted by weaker market demand. Accordingly, the Company determined that a triggering event occurred requiring an interim goodwill impairment test for its European reporting unit as of September 28, 2024. The impairment test indicated a pre-tax, non-cash goodwill impairment charge related to the Europe reporting unit of $63.4 million, which the Company recorded during the three months ended September 28, 2024. A significant or prolonged deterioration in economic conditions, a further decline in projected future cash flows, or increases in the discount rates, could impact the Company’s assumptions and require a reassessment of goodwill for impairment in future periods. Future declines in estimated after tax cash flows, increases in the discount rates or a decline in market capitalization could result in an additional indication of impairment in one or more of the Company’s reporting units. The following table summarizes the changes in goodwill by reportable segment: (amounts in thousands) North Europe Total Gross carrying amount at December 31, 2023 $ 182,412 $ 268,512 $ 450,924 Sale of business (900) — (900) Foreign currency translation (114) 1,536 1,422 Gross carrying amount at September 28, 2024 $ 181,398 $ 270,048 $ 451,446 Accumulated impairment losses at December 31, 2023 $ — $ (60,754) $ (60,754) Impairment — (63,445) (63,445) Foreign currency translation — (841) (841) Accumulated impairment losses at September 28, 2024 $ — $ (125,040) $ (125,040) Balance, net of impairment at September 28, 2024 $ 181,398 $ 145,008 $ 326,406

Intangible Assets, Net

Intangible Assets, Net	9 Months Ended
	Sep. 28, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible Assets, Net	Intangible Assets, Net The cost and accumulated amortization values of our intangible assets were as follows: September 28, 2024 (amounts in thousands) Cost Accumulated Net Customer relationships and agreements $ 124,094 $ (91,655) $ 32,439 Software 72,067 (28,647) 43,420 Trademarks and trade names 32,204 (12,089) 20,115 Patents, licenses and rights 12,673 (5,327) 7,346 Total amortizable intangibles $ 241,038 $ (137,718) $ 103,320 December 31, 2023 (amounts in thousands) Cost Accumulated Net Customer relationships and agreements $ 123,713 $ (84,281) $ 39,432 Software 113,429 (58,424) 55,005 Trademarks and trade names 32,148 (10,802) 21,346 Patents, licenses and rights 12,666 (4,539) 8,127 Total amortizable intangibles $ 281,956 $ (158,046) $ 123,910 We recorded accelerated amortization of $14.1 million during the nine months ended September 28, 2024 and $3.5 million in the three and nine months ended September 30, 2023, respectively, for an ERP that we are no longer utilizing after we completed our related obligations under the JW Australia Transition Services Agreement during the first quarter of 2024. The expense was recorded within SG&A The effect on our carrying value of intangible assets due to currency translations for foreign intangible assets was an increase of $0.1 million as of September 28, 2024 compared to December 31, 2023. Amortization expense was recorded as follows: Three Months Ended Nine Months Ended (amounts in thousands) September 28, 2024 September 30, 2023 September 28, 2024 September 30, 2023 Amortization expense $ 4,713 $ 9,166 $ 28,536 $ 21,166

Accrued Expenses and Other Curr

Accrued Expenses and Other Current Liabilities	9 Months Ended
	Sep. 28, 2024
Payables and Accruals [Abstract]
Accrued Expenses and Other Current Liabilities	Accrued Expenses and Other Current Liabilities (amounts in thousands) September 28, 2024 December 31, 2023 Accrued sales and advertising rebates $ 75,908 $ 82,732 Current portion of operating lease liability 35,327 32,477 Non-income related taxes 26,348 20,072 Current portion of warranty liability (Note 9) 18,126 22,819 Accrued freight 16,192 18,963 Current portion of accrued claim costs relating to self-insurance programs 15,509 14,079 Accrued expenses 14,779 15,758 Current portion of restructuring accrual ( Note 16 ) 14,614 3,375 Accrued interest payable 10,989 1,401 Legal claims provision ( Note 21 ) 8,228 2,683 Current portion of UTPs (Note 11) 6,864 — Deferred revenue and customer deposits 6,764 7,189 Current portion of derivative liability (Note 19) 2,170 2,996 Accrued income taxes payable 1,309 9,252 Total accrued expenses and other current liabilities $ 253,127 $ 233,796 The legal claims provision relates primarily to contingencies associated with the ongoing legal matters disclosed in Note 21 - Commitments and Contingencies. The accrued sales and advertising rebates, accrued interest payable, accrued freight, and non-income related taxes can fluctuate significantly period-over-period due to timing of payments.

Warranty Liability

Warranty Liability	9 Months Ended
	Sep. 28, 2024
Product Warranties Disclosures [Abstract]
Warranty Liability	Warranty Liability Warranty terms range from one year to lifetime on certain window and door components. Warranties are normally limited to servicing or replacing defective components for the original customer. Product defects arising within six months of sale are classified as manufacturing defects and are not included in the current period expense below. Some warranties are transferable to subsequent owners and are either limited to 10 years from the date of manufacture or require pro rata payments from the customer. Estimated warranty costs based on historical experience are recorded as a provision at the time of sale. The provision is adjusted periodically to reflect actual experience. An analysis of our warranty liability is as follows: (amounts in thousands) September 28, 2024 September 30, 2023 Balance as of January 1 $ 53,247 $ 52,389 Current period charges 14,741 23,930 Experience adjustments 633 (992) Payments (21,792) (22,925) Currency translation (64) (101) Balance at period end 46,765 52,301 Current portion (18,126) (22,034) Long-term portion $ 28,639 $ 30,267 The most significant component of our warranty liability was in the North America segment. As of September 28, 2024, the warranty liability in the North America segment totaled $40.4 million, after discounting future estimated cash flows at rates between 3.49% and 3.75%. Without discounting, the liability would have increased by approximately $2.9 million.

Long-Term Debt

Long-Term Debt	9 Months Ended
	Sep. 28, 2024
Debt Disclosure [Abstract]
Long-Term Debt	Long-Term Debt Our long-term debt, net of original issue discount and unamortized debt issuance costs, consisted of the following: September 28, 2024 September 28, 2024 December 31, 2023 (amounts in thousands) Interest Rate Senior Notes 4.88% - 7.00% $ 750,000 $ 600,000 Term Loan Facility 7.36% (1) 383,569 536,250 Finance leases and other financing arrangements 1.00% - 8.95% (1) 64,884 74,460 Mortgage notes 5.44% - 5.94% (1) 21,347 22,070 Total Debt 1,219,800 1,232,780 Unamortized debt issuance costs and original issue discounts (9,063) (6,528) Current maturities of long-term debt (30,854) (36,177) Long-term debt $ 1,179,883 $ 1,190,075 (1) Term Loan B, mortgage notes and certain finance leases and other financing arrangements are subject to variable interest rates. Summaries of our significant changes to outstanding debt agreements as of September 28, 2024 are as follows: Senior Secured Notes and Senior Notes In December 2017, we issued $800.0 million of Senior Notes in two tranches: $400.0 million bearing interest at 4.63% and maturing in December 2025, and $400.0 million bearing interest at 4.88% and maturing in December 2027 in a private placement for resale to qualified institutional buyers pursuant to Rule 144A under the Securities Act. In May 2020, we issued $250.0 million of Senior Secured Notes bearing interest at 6.25% and maturing in May 2025 in a private placement for resale to qualified institutional buyers pursuant to Rule 144A under the Securities Act. The proceeds were net of fees and expenses associated with debt issuance, including an underwriting fee of 1.25%. Interest is payable semiannually, in arrears, each May and November. On August 3, 2023, we redeemed all $250.0 million of our 6.25% Senior Secured Notes and $200.0 million of our 4.63% Senior Notes. The Company recognized a pre-tax loss of $6.5 million on the redemption in the third quarter of 2023, consisting of $3.9 million in call premium and $2.6 million in accelerated amortization of debt issuance costs. In August 2024, we issued $350.0 million of Senior Notes bearing interest at 7.00% and maturing September 2032 in a private placement for resale to qualified institutional buyers pursuant to Rule 144A under the Securities Act. The proceeds were net of fees and expenses associated with debt issuance including an underwriting fee of 1.25%. We incurred debt issuance costs of $5.5 million which will be amortized to interest expense over the life of the notes using the effective interest method. Interest is payable semiannually, in arrears, each March and September. In September 2024, we redeemed the remaining $200.0 million of our 4.63% Senior Notes. The Company recognized a pre-tax loss of $0.5 million on the redemption in the third quarter of 2024, consisting entirely in accelerated amortization of debt issuance costs. Term Loan Facility U.S. Facility - Initially executed in October 2014, we amended the Term Loan Facility in July 2021 to, among other things, extend the maturity date from December 2024 to July 2028 and provide additional covenant flexibility. Pursuant to the amendment, certain existing and new lenders advanced $550.0 million of replacement term loans, the proceeds of which were used to prepay in full the amount outstanding under the previously existing term loans. The replacement term loans originally bore interest at LIBOR (subject to a floor of 0.00%) plus a margin of 2.00% to 2.25% depending on JWI’s corporate credit ratings. In addition, the amendment also modified certain other terms and provisions of the Term Loan Facility, and adds language to address the replacement of LIBOR with a SOFR basis upon the June 30, 2023 cessation of the publication of LIBOR. Voluntary prepayments of the replacement term loans are permitted at any time, in certain minimum principal amounts, but were subject to a 1.00% premium during the first six months. The amendment requires 0.25% of the initial principal to be repaid quarterly until maturity. In June 2023, we amended the Term Loan Facility to replace LIBOR with a Term SOFR based rate as the successor benchmark rate and made certain other technical amendments and related conforming changes. All other material terms and conditions were unchanged. In January 2024, we amended the Term Loan Facility to lower the applicable margin for replacement term loans, remove certain provisions no longer relevant to the parties, and make certain other technical amendments and related conforming changes. Pursuant to the amendment, replacement term loans bear interest at SOFR plus a margin of 1.75% to 2.00% depending on JWI’s corporate credit ratings, compared to a margin of 2.00% to 2.25% under the previous amendment. All other material terms and conditions of the Term Loan Agreement were unchanged. As a result of this amendment, we recognized debt extinguishment and refinancing costs of $1.4 million, which included $0.8 million of unamortized debt issuance costs and original discount fees. In August 2024, we utilized a portion of the proceeds received from our issuance of $350.0 million of Senior Notes to repay $150.0 million of the outstanding balance of our Term Loan Facility. As of September 28, 2024, the outstanding principal balance, net of original issue discount, was $383.1 million . In May 2020, we entered into interest rate swap agreements with a weighted average fixed rate of 0.395% paid against one-month LIBOR floored at 0.00% with outstanding notional amounts aggregating to $370.0 million corresponding to that amount of the debt outstanding under our Term Loan Facility. In June 2023, the interest rate swap agreements were amended to convert to a SOFR basis on June 30, 2023, resulting in a weighted average fixed rate of 0.317% paid against one-month USD-SOFR CME Term floored at (0.10)%. The interest rate swap agreements were designated as cash flow hedges of a portion of the interest obligations on our Term Loan Facility borrowings and matured in December 2023. See Note 19 - Derivative Financial Instruments for additional information on our derivative assets and liabilities. In February 2024, we entered into interest rate collar agreements with a cap rate of 4.50% paid against one-month USD-SOFR CME Term floored at 3.982% and 3.895% with outstanding notional amounts aggregating to $100.0 million corresponding to that amount of the debt outstanding under our Term Loan Facility. The interest rate collar agreements were designated as cash flow hedges of a portion of the interest obligations on our Term Loan Facility borrowings and mature in February 2026. See Note 19 - Derivative Financial Instruments for additional information on our derivative assets and liabilities. Revolving Credit Facility ABL Facility - Initially executed in 2014, extensions of credit under our ABL Facility are limited by a borrowing base calculated based on specified percentages of the value of eligible accounts receivable and inventory, subject to certain reserves and other adjustments. We pay a fee of 0.25% on the unused portion of the commitments. The ABL Facility has a minimum fixed charge coverage ratio that we are obligated to comply with under certain circumstances. The ABL Facility has various non-financial covenants, including restrictions on liens, indebtedness, dividends, customary representations and warranties, and customary events of defaults and remedies. In July 2021, we amended the ABL Facility to, among other things, extend the maturity date from December 2022 to July 2026, increase the aggregate commitment to $500.0 million, provide additional covenant flexibility, conform certain terms and provisions to the Term Loan Facility, and amend the interest rate grid applicable to the loans thereunder by adding language to address the replacement of LIBOR with a SOFR basis upon the June 30, 2023 cessation of the publication of LIBOR. Pursuant to the amendment, the amount allocated to U.S. borrowers was increased to $465.0 million. The amount allocated to Canadian borrowers was maintained at $35.0 million. Borrowings under the ABL Facility bore, at the borrower’s option, interest at either a base rate plus a margin of 0.25% to 0.50% depending on excess availability or LIBOR (subject to a floor of 0.00%) plus a margin of 1.25% to 1.50% depending on excess availability. All other material terms and conditions were unchanged. In June 2023, we amended the ABL Facility to replace LIBOR with a Term SOFR based rate as the successor benchmark rate and made certain other technical amendments and related conforming changes. All other material terms and conditions were unchanged. As of September 28, 2024, we had no outstanding borrowings, $2.8 million in letters of credit and $428.2 million available under the ABL Facility. Mortgage Notes – In December 2007, we entered into thirty-year mortgage notes secured by land and buildings in Denmark with principal payments which began in 2018. As of September 28, 2024, we had DKK 142.5 million ($21.3 million) outstanding under these notes. Finance leases and other financing arrangements – In addition to finance leases, we include insurance premium financing arrangements and loans secured by equipment in this category. As of September 28, 2024, we had $64.9 million outstanding in this category, with maturities ranging from 2024 to 2031. As of September 28, 2024, we were in compliance with the terms of all of our Credit Facilities and the indentures governing the Senior Notes.

Income Taxes

Income Taxes	9 Months Ended
	Sep. 28, 2024
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes The effective income tax rate for continuing operations was (11.0)% and (12.6)% for the three and nine months ended September 28, 2024, respectively, and 50.7% and 39.8% for the three and nine months ended September 30, 2023, respectively. In accordance with ASC 740-270, we recorded an income tax expense of $7.3 million and $13.4 million from continuing operations in the three and nine months ended September 28, 2024, respectively, and an income tax expense of $17.4 million and $31.6 million from continuing operations in the three and nine months ended September 30, 2023 , respectively. We applied our estimated annual effective tax rate to year-to-date income for includable entities during the respective periods. Entities that are currently generating losses and for which there is a full valuation allowance are excluded from the worldwide effective tax rate calculation and are calculated separately. The impact of significant discrete items is separately recognized in the quarter in which they occur. The tax expense for discrete items included in the tax provision for continuing operations for the three months ended September 28, 2024 was $4.8 million , compared to a tax expense of $7.0 million for the three months ended September 30, 2023. The discrete tax expense amounts for the three months ended September 28, 2024 comprised primarily of $2.4 million of tax expense due to changes in UTPs from ongoing audits and $2.6 million attributable to an increase in the valuation allowance recorded against our U.S. tax attributes due to changes in estimated forecasted earnings. The discrete tax expense amounts for the three months ended September 30, 2023 comprised primarily of $5.7 million of tax expense attributable to an increase in the valuation allowance on U.S. foreign tax credit carryforwards and a net $2.3 million of tax expense due to changes in UTPs, partially offset by a $0.9 million net tax benefit attributable to the decrease in the valuation allowance on U.S. state net operating losses. The tax expense for discrete items included in the tax provision for continuing operations for the nine months ended September 28, 2024 was $16.8 million , compared to a tax expense of $9.6 million for the nine months ended September 30, 2023 . The discrete tax expense amounts for the nine months ended September 28, 2024 comprised primarily of $12.1 million of tax expense due to changes in UTPs from ongoing audits and $4.3 million attributable to an increase in the valuation allowance recorded against our U.S. tax attributes due to changes in estimated forecasted earnings. The di screte tax expense amounts for the nine months ended September 30, 2023 comprised primarily of $5.7 million of tax expense attributable to an increase in the valuation allowance on U.S. foreign tax credit carryforwards, a net $2.0 million of tax expense due to changes in UTPs, $1.6 million of tax expense attributable to share-based compensation and a $0.6 million increase in the valuation allowance in U.S. state net operating losses. Under ASC 740-10, we provide for UTPs and the related interest expense by adjusting unrecognized tax benefits and accrued interest accordingly. We recognize potential interest and penalties related to unrecognized tax benefits in income tax expense. As of September 28, 2024 and December 31, 2023, we had a liability for unrecognized tax benefits without regard to accrued interest of $49.5 million and $38.9 million, respectively. As of September 28, 2024, $6.9 million of our liability for unrecognized tax benefits without regard to accrued interest was included in accrued expenses and other current liabilities in the accompanying consolidated balance sheet. The U.S. Congress, the OECD, the EU and other government agencies in jurisdictions in which we and our affiliates do business have maintained a focus on the taxation of multinational companies. During 2023, the OECD issued administrative guidance for Pillar Two, which generally imposes a 15% global minimum tax on multinational companies. Many Pillar Two rules are effective for fiscal years beginning on January 1, 2024, with other aspects to be effective from 2025. We regularly monitor developments in our jurisdictions and consider the impact of the tax-related proposals as they arise. We do not expect the minimum tax to have a material impact on our financial statements. As of September 28, 2024 , the Company maintained a partial indefinite reinvestment assertion on its post - 2017 undistributed foreign earnings.

Segment Information

Segment Information	9 Months Ended
	Sep. 28, 2024
Segment Reporting [Abstract]
Segment Information	Segment Information We report our segment information in the same way management internally organizes the business to assess performance and make decisions regarding allocation of resources in accordance with ASC 280-10 - Segment Reporting . Management reviews net revenues and Adjusted EBITDA from continuing operations to evaluate segment performance and allocate resources. We define Adjusted EBITDA from continuing operations as income (loss) from continuing operations, net of tax, adjusted for the following items: income tax expense (benefit); depreciation and amortization; interest expense (income), net; and certain special items consisting of non-recurring net legal and professional expenses and settlements; goodwill impairment; restructuring and asset-related charges; M&A related costs; net (gain) loss on sale of business, property, and equipment; loss on extinguishment and refinancing of debt; share-based compensation expense; non-cash foreign exchange transaction/translation (gain) loss; and other special items. We have two reportable segments, organized and managed principally in geographic regions: North America and Europe. We report all other business activities in Corporate and unallocated costs. Factors considered in determining the two reportable segments include the nature of business activities, the management structure accountable directly to the CODM, the discrete financial information regularly reviewed by the CODM, and information presented to the Board of Directors and investors. No operating segments have been aggregated for our presentation of reportable segments. The following tables set forth certain information relating to our segments’ operations: (amounts in thousands) North Europe Corporate Total Three Months Ended September 28, 2024 Total net revenues $ 677,992 $ 259,384 $ — $ 937,376 Intersegment net revenues (47) (2,613) — (2,660) Net revenues from external customers $ 677,945 $ 256,771 $ — $ 934,716 Three Months Ended September 30, 2023 Total net revenues $ 790,327 $ 289,692 $ — $ 1,080,019 Intersegment net revenues (42) (2,997) — (3,039) Net revenues from external customers $ 790,285 $ 286,695 $ — $ 1,076,980 (amounts in thousands) North Europe Corporate Total Nine Months Ended September 28, 2024 Total net revenues $ 2,068,645 $ 816,263 $ — $ 2,884,908 Intersegment net revenues (107) (4,943) — (5,050) Net revenues from external customers $ 2,068,538 $ 811,320 $ — $ 2,879,858 Nine Months Ended September 30, 2023 Total net revenues $ 2,375,633 $ 911,875 $ — $ 3,287,508 Intersegment net revenues (203) (4,036) — (4,239) Net revenues from external customers $ 2,375,430 $ 907,839 $ — $ 3,283,269 Three Months Ended September 28, 2024 (amounts in thousands) North America Europe Corporate and Unallocated Costs Total Consolidated Income (loss) from continuing operations, net of tax $ 35,781 $ (66,662) $ (42,081) $ (72,962) Income tax expense (benefit) 6,455 2,626 (1,830) 7,251 Depreciation and amortization 18,142 7,884 1,848 27,874 Interest expense (income), net 819 (14) 15,514 16,319 Special items: Net legal and professional expenses and settlements 619 995 10,662 12,276 Goodwill impairment — 63,445 — 63,445 Restructuring and asset-related charges 17,124 7,786 630 25,540 M&A related costs — — 3,045 3,045 Net (gain) loss on sale of business, property, and equipment (5,288) 33 (166) (5,421) Loss on extinguishment and refinancing of debt — — 459 459 Share-based compensation expense 349 346 1,764 2,459 Non-cash foreign exchange transaction/translation loss (gain) 53 (475) 59 (363) Other special items 734 291 696 1,721 Adjusted EBITDA from continuing operations $ 74,788 $ 16,255 $ (9,400) $ 81,643 Three Months Ended September 30, 2023 (amounts in thousands) North America Europe Corporate and Unallocated Costs Total Consolidated Income (loss) from continuing operations, net of tax $ 40,469 $ 10,672 $ (34,233) $ 16,908 Income tax expense (benefit) 27,412 5,974 (15,987) 17,399 Depreciation and amortization (1) 17,128 7,482 6,341 30,951 Interest expense, net 604 147 15,986 16,737 Special items: Net legal and professional expenses and settlements 802 1,264 5,335 7,401 Restructuring and asset-related charges 11,890 838 (30) 12,698 M&A related costs 84 — 1,118 1,202 Net loss (gain) on sale property and equipment 748 (4,791) 3 (4,040) Loss on extinguishment and refinancing of debt — — 6,487 6,487 Share-based compensation expense 914 455 2,013 3,382 Non-cash foreign exchange transaction/translation loss (gain) 131 2,343 (2,203) 271 Other special items (220) 67 (3,502) (3,655) Adjusted EBITDA from continuing operations $ 99,962 $ 24,451 $ (18,672) $ 105,741 (1) Corporate and unallocated depreciation and amortization expense includes software accelerated amortization of $3.5 million for an ERP that we are no longer utilizing after we completed our related obligations under the JW Australia Transition Services Agreement during the first quarter of 2024. To conform with current period presentation, certain amounts in prior period information have been reclassified. Nine Months Ended September 28, 2024 (amounts in thousands) North America Europe Corporate and Unallocated Costs Total Consolidated Income (loss) from continuing operations, net of tax $ 82,783 $ (71,665) $ (130,301) $ (119,183) Income tax expense (benefit) 26,800 15,784 (29,201) 13,383 Depreciation and amortization (1) 55,033 22,940 19,579 97,552 Interest expense, net 2,137 917 45,521 48,575 Special items: Net legal and professional expenses and settlements 2,336 2,367 45,109 49,812 Goodwill impairment — 63,445 — 63,445 Restructuring and asset-related charges 40,249 18,411 1,386 60,046 M&A related costs — — 9,223 9,223 Net gain on sale of business, property, and equipment (7,839) (153) (184) (8,176) Loss on extinguishment and refinancing of debt — — 1,908 1,908 Share-based compensation expense 2,610 994 8,988 12,592 Non-cash foreign exchange transaction/translation loss (gain) 315 (3,771) 355 (3,101) Other special items 7,199 1,911 4 9,114 Adjusted EBITDA from continuing operations $ 211,623 $ 51,180 $ (27,613) $ 235,190 (1) Corporate and unallocated depreciation and amortization expense includes software accelerated amortization of $14.1 million for an ERP that we are no longer utilizing after we completed our related obligations under the JW Australia Transition Services Agreement during the first quarter of 2024. Nine Months Ended September 30, 2023 (amounts in thousands) North America Europe Corporate and Unallocated Costs Total Consolidated Income (loss) from continuing operations, net of tax $ 126,987 $ 28,627 $ (107,739) $ 47,875 Income tax expense (benefit) 63,072 10,469 (41,903) 31,638 Depreciation and amortization (1) 62,625 22,414 12,469 97,508 Interest expense, net 4,188 692 54,203 59,083 Special items: Net legal and professional expenses and settlements 804 3,720 9,085 13,609 Restructuring and asset-related charges 25,360 2,620 796 28,776 M&A related costs 651 — 4,520 5,171 Net loss (gain) on sale of property and equipment 1,132 (5,088) 3 (3,953) Loss on extinguishment and refinancing of debt — — 6,487 6,487 Share-based compensation expense 3,366 1,438 7,451 12,255 Non-cash foreign exchange transaction/translation (gain) loss (168) 1,192 (1,921) (897) Other special items (39) (134) (3,450) (3,623) Adjusted EBITDA from continuing operations $ 287,978 $ 65,950 $ (59,999) $ 293,929 (1) Corporate and unallocated depreciation and amortization expense includes software accelerated amortization of $3.5 million for an ERP that we are no longer utilizing after we completed our related obligations under the JW Australia Transition Services Agreement during the first quarter of 2024. North America depreciation and amortization expense includes accelerated depreciation of $9.1 million from reviews of equipment capacity optimization. To conform with current period presentation, certain amounts in prior period information have been reclassified. Reconciliations of income from continuing operations, net of tax to Adjusted EBITDA from continuing operations are as follows: Three Months Ended Nine Months Ended (amounts in thousands) September 28, 2024 September 30, 2023 September 28, 2024 September 30, 2023 (Loss) income from continuing operations, net of tax $ (72,962) $ 16,908 (119,183) 47,875 Income tax expense 7,251 17,399 13,383 31,638 Depreciation and amortization (1) 27,874 30,951 97,552 97,508 Interest expense, net 16,319 16,737 48,575 59,083 Special items: Net legal and professional expenses and settlements (2) 12,276 7,401 49,812 13,609 Goodwill impairment (3) 63,445 — 63,445 — Restructuring and asset-related charges (4)(5) 25,540 12,698 60,046 28,776 M&A related costs (6) 3,045 1,202 9,223 5,171 Net gain on sale of business, property, and equipment (7) (5,421) (4,040) (8,176) (3,953) Loss on extinguishment and refinancing of debt (8) 459 6,487 1,908 6,487 Share-based compensation expense (9) 2,459 3,382 12,592 12,255 Non-cash foreign exchange transaction/translation (gain) loss (10) (363) 271 (3,101) (897) Other special items (11) 1,721 (3,655) 9,114 (3,623) Adjusted EBITDA from continuing operations $ 81,643 $ 105,741 $ 235,190 $ 293,929 (1) Depreciation and amortization expense includes accelerated amortization of $14.1 million in the nine months ended September 28, 2024 and $3.5 million in the three and nine months ended September 30, 2023 in Corporate and unallocated costs for an ERP that we are no longer utilizing after we completed our related obligations under the JW Australia Transition Services Agreement during the first quarter of 2024. In addition, depreciation and amortization expense in the nine months ended September 30, 2023 includes accelerated depreciation of $9.1 million in North America from reviews of equipment capacity optimization. (2) Net legal and professional expenses and settlements include non-recurring transformation journey expenses of $12.0 million and $46.6 million in the three and nine months ended September 28, 2024, respectively, and $7.1 million and $12.0 million in the three and nine months ended September 30, 2023, respectively. These expenses primarily relate to the engagement of one transformation consultant for a period spanning from the third quarter of 2023 through the fourth quarter of 2024, for which we incurred $7.0 million and $35.4 million in the three and nine months ended September 28, 2024, respectively, and $5.8 million and $6.2 million in the three and nine months ended September 30, 2023, respectively. Additionally, net legal and professional expenses and settlements include amounts relating to litigation of historic legal matters of $0.2 million and $2.8 million in the three and nine months ended September 28, 2024, respectively, and of $0.2 million and $1.6 million and in the three and nine months ended September 30, 2023, respectively. (3) Goodwill impairment consists of goodwill impairment charges associated with our Europe reporting unit. (4) Represents severance, accelerated depreciation and amortization, equipment relocation and other expenses directly incurred as a result of restructuring events. The restructuring charges primarily relate to charges incurred to change the operating structure, eliminate certain roles, and close certain manufacturing facilities in our North America and Europe segments. (5) For the three and nine months ended September 28, 2024, $1.4 million and $7.8 million, respectively, of product and inventory-related charges related to announced facility closures were detrimental to Adjusted EBITDA. (6) M&A related costs consists primarily of legal and professional expenses related to the potential disposition of Towanda. (7) Net gain on sale of business, property, and equipment in the three months ended September 28, 2024 primarily relates to the sale of our St. Kitts business. Net gain on sale of business, property, and equipment in the nine months ended September 28, 2024 primarily relates to the sale of our business in St. Kitts and property in Chile. Net gain on sale of business, property and equipment in the three and nine months ended September 30, 2023 primarily relates to the sale of a building in Melton, UK. (8) Loss on extinguishment and refinancing of debt of $0.5 million in the three months ended September 28, 2024 is related to the redemption of the remaining $200.0 million of our 4.63% Senior Notes. Loss on extinguishment and refinancing of debt of $1.9 million in the nine months ended September 28, 2024 associated with an amendment of our Term Loan Facility and redemption of the remaining $200.0 million of our 4.63% Senior Notes. Loss on extinguishment and refinancing of debt of $6.5 million in the three and nine months ended September 30, 2023 is related to the redemption of $250.0 million of our 6.25% Senior Secured Notes and $200.0 million of our 4.63% Senior Notes. (9) Represents non-cash equity-based compensation expense related to the issuance of share-based awards. (10) Non-cash foreign exchange transaction/translation gain primarily associated with fair value adjustments of foreign currency derivatives and revaluation of balances denominated in foreign currencies. (11) Other special items not core to ongoing business activity include: (i) in the three months ended September 30, 2023, ($3.1) million in income from short-term investments and forward contracts related to the JW Australia divestiture; (ii) in the nine months ended September 28, 2024, a loss of $4.3 million of cumulative foreign currency translation adjustments related to the substantial liquidation of a foreign subsidiary in Chile in our North America segment, a one-time realized foreign currency loss of $1.6 million in our Europe segment related to a cash repatriation event, and ($1.5) million of cash received on an impaired note in Corporate and unallocated costs; and (iii) in the nine months ended September 30, 2023, ($3.1) million in income from short-term investments and forward contracts related to the JW Australia divestiture. To conform with current period presentation, certain amounts in prior period information have been reclassified.

Capital Stock

Capital Stock	9 Months Ended
	Sep. 28, 2024
Equity [Abstract]
Capital Stock	Capital Stock Preferred Stock - Our Board of Directors is authorized to issue Preferred Stock from time to time in one or more series and with such rights, privileges, and preferences as the Board of Directors shall from time to time determine. We have not issued any shares of Preferred Stock. Common Stock - Common Stock includes the basis of shares outstanding plus amounts recorded as additional paid-in capital. Shares outstanding exclude the shares issued to the Employee Benefit Trust that are considered similar to treasury shares and total 193,941 shares at both September 28, 2024 and December 31, 2023 with a total original issuance value of $12.4 million. We record share repurchases on their trade date and reduce shareholders’ equity and increase accounts payable. Repurchased shares are retired, and the excess of the repurchase price over the par value of the shares is charged to retained earnings. On July 28, 2022, our Board of Directors decreased our previous repurchase authorization of $400.0 million to a total aggregate value of $200.0 million with no expiration date. As of September 28, 2024, $175.7 million was remaining under the repurchase program. During the nine months ended September 28, 2024, we repurchased 1,600,000 shares of our Common Stock at an average price of $15.18. We did not repurchase shares of our Common Stock during the three months ended September 28, 2024, nor the three and nine months ended September 30, 2023.

Earnings Per Share

Earnings Per Share	9 Months Ended
	Sep. 28, 2024
Earnings Per Share [Abstract]
Earnings Per Share	Earnings Per Share The basic and diluted income per share calculations were determined based on the following share data : Three Months Ended Nine Months Ended September 28, 2024 September 30, 2023 September 28, 2024 September 30, 2023 Weighted average outstanding shares of Common Stock basic 84,554,174 85,182,678 85,115,070 84,915,519 Restricted stock units, performance share units and options to purchase Common Stock — 1,167,162 — 813,617 Weighted average outstanding shares of Common Stock diluted 84,554,174 86,349,840 85,115,070 85,729,136 For the three and nine months ended September 28, 2024, we had net losses from operations. As a result, no potentially dilutive securities were included in the denominator for computing diluted loss per share as their inclusion would have been antidilutive. The following table provides the securities that could potentially dilute basic earnings per share in the future but were not included in the computation of diluted income per share as their inclusion would be anti-dilutive: Three Months Ended Nine Months Ended September 28, 2024 September 30, 2023 September 28, 2024 September 30, 2023 Common Stock options 1,209,341 1,384,007 1,243,831 1,678,769 Restricted stock units 951,656 18,161 1,087,802 41,552 Performance share units 296,521 25,774 276,400 229,841

Stock Compensation

Stock Compensation	9 Months Ended
	Sep. 28, 2024
Share-Based Payment Arrangement [Abstract]
Stock Compensation	Stock Compensation The activity under our incentive plans for the periods presented are reflected in the following tables: Three Months Ended September 28, 2024 September 30, 2023 Shares Weighted Average Exercise Price Per Share Shares Weighted Average Exercise Price Per Share Options granted 9,900 $ 12.97 — $ — Options cancelled 207,958 $ 21.66 199,395 $ 21.18 Options exercised 28,694 $ 13.08 4,763 $ 8.14 Shares Weighted Average Grant Date Fair Value Shares Weighted Average Grant Date Fair Value RSUs granted 70,729 $ 14.60 78,400 $ 15.48 PSUs granted 16,388 $ 13.94 — $ — Nine Months Ended September 28, 2024 September 30, 2023 Shares Weighted Average Exercise Price Per Share Shares Weighted Average Exercise Price Per Share Options granted 375,312 $ 18.37 262,809 $ 13.28 Options cancelled 282,429 $ 20.61 277,285 $ 21.35 Options exercised 220,602 $ 13.03 24,478 $ 9.50 Shares Weighted Average Grant Date Fair Value Shares Weighted Average Grant Date Fair Value RSUs granted 1,006,817 $ 18.32 1,568,729 $ 13.37 PSUs granted 433,735 $ 22.27 307,273 $ 17.38 Share-based compensation expense w as $2.5 million and $12.6 million for the three and nine months ended September 28, 2024 and $3.4 million and $12.3 million for the three and nine months ended September 30, 2023, respectively. As of September 28, 2024, we had $17.5 million of total unrecognized compensation expense related to non-vested share-based compensation arrangements. This cost is expected to be recognized over the remaining weighted-average vesting period of 1.48 years.

Restructuring and Asset-Related

Restructuring and Asset-Related Charges	9 Months Ended
	Sep. 28, 2024
Restructuring and Related Activities [Abstract]
Restructuring and Asset-Related Charges	Restructuring and Asset-Related Charges We engage in restructuring activities focused on improving productivity and operating margins. Restructuring costs primarily relate to costs associated with workforce reductions, plant consolidations and closures, and changes to the management structure to align with our operations. Other restructuring associated costs primarily consist of equipment relocation and facility restoration costs. Asset-related charges consist of accelerated depreciation and amortization of assets due to changes in asset useful lives. The following table summarizes the restructuring and asset-related charges for the periods indicated: (amounts in thousands) North Europe Corporate Total Three Months Ended September 28, 2024 Restructuring severance and employee-related charges $ 5,290 $ 5,880 $ 630 $ 11,800 Other restructuring associated costs 3,025 1,906 — 4,931 Asset-related charges 8,809 — — 8,809 Other restructuring associated costs and asset-related charges 11,834 1,906 — 13,740 Total restructuring and asset-related charges $ 17,124 $ 7,786 $ 630 $ 25,540 Three Months Ended September 30, 2023 Restructuring severance and employee-related charges (income) $ 7,578 $ 801 $ (30) $ 8,349 Other restructuring associated costs 2,790 37 — 2,827 Asset-related charges 1,522 — — 1,522 Other restructuring associated costs and asset-related charges 4,312 37 — 4,349 Total restructuring and asset-related charges (income), net $ 11,890 $ 838 $ (30) $ 12,698 (amounts in thousands) North Europe Corporate Total Nine Months Ended September 28, 2024 Restructuring severance and employee-related charges $ 16,241 $ 13,155 $ 1,190 $ 30,586 Other restructuring associated costs 7,133 4,325 — 11,458 Asset-related charges 16,875 931 196 18,002 Other restructuring associated costs and asset-related charges 24,008 5,256 196 29,460 Total restructuring and asset-related charges $ 40,249 $ 18,411 $ 1,386 $ 60,046 Nine Months Ended September 30, 2023 Restructuring severance and employee-related charges $ 10,920 $ 3,594 $ 796 $ 15,310 Other restructuring associated costs (income) 9,681 (1,154) — 8,527 Asset-related charges 4,759 180 — 4,939 Other restructuring associated costs and asset-related charges (income) 14,440 (974) — 13,466 Total restructuring and asset-related charges $ 25,360 $ 2,620 $ 796 $ 28,776 The following is a summary of the restructuring accruals recorded and charges incurred: (amounts in thousands) September 28, 2024 September 30, 2023 Balance as of January 1 $ 3,375 $ 5,021 Current period charges 42,044 23,837 Payments (30,759) (21,831) Currency translation (46) 95 Balance at period end $ 14,614 $ 7,122 Restructuring accruals are expected to be paid within the next 12 months and are included within accrued expenses and other current liabilities in the consolidated balance sheet. On April 11, 2024, we announced plans to close two manufacturing facilities, located in Vista, California and Hawkins, Wisconsin in a continuing effort to simplify our footprint and drive operational efficiencies. As of September 28, 2024 the remaining restructuring accrual for these plans is $5.5 million and the remaining cash outlay is expected to be $17.3 million. We expect to substantially complete the facility closures by the first quarter of 2025. Costs and cash outlays associated with the plans: North America: Vista, California and Hawkins, Wisconsin Total Estimated Costs Cumulative Costs to-date Costs in the Three Months Ended Costs in the Nine Months Ended (amounts in thousands) September 28, 2024 September 28, 2024 Restructuring severance and employee-related charges (1) $ 11,300 $ 10,714 $ 168 $ 10,714 Other restructuring associated costs (1) 7,400 3,615 2,260 3,615 Product-related cash charges (2) 5,000 4,086 1,436 4,086 Total cash charges 23,700 18,415 3,864 18,415 Asset-related charges (1) 12,100 11,984 8,769 11,984 Inventory and other product-related non-cash charges (3) 4,100 3,706 — 3,706 Total non-cash charges 16,200 15,690 8,769 15,690 Total costs $ 39,900 $ 34,105 $ 12,633 $ 34,105 Total cash outlays $ 29,600 $ 12,265 $ 6,586 $ 12,265 (1) The charges incurred in the three and nine months ended September 28, 2024 were included in restructuring and asset-related charges in the accompanying Consolidated Statement of Operations. (2) The product-related cash charges incurred in the three and nine months ended September 28, 2024 were detrimental to Net Sales in the accompanying Consolidated Statement of Operations. (3) The inventory and other product-related non-cash charges in the three and nine months ended September 28, 2024 were included in Cost of Sales in the accompanying Consolidated Statement of Operations. During 2023, we announced plans to transform our European operations by changing the operating structure, eliminating certain roles and rationalizing our manufacturing footprint. We plan to close two manufacturing facilities and transfer production to other facilities within Europe. During the nine months ended September 28, 2024, we announced additional plans, increasing the total estimated costs by approximately $6.3 million to $27.1 million, after identifying additional opportunities to optimize our European operating structure. As of September 28, 2024 the remaining restructuring accrual for these plans is $5.4 million and the remaining cash outlay is expected to be $11.0 million. We expect to substantially complete these initiatives by the end of 2024. Costs and cash outlays associated with the plans: Europe Total Estimated Costs Cumulative Costs to-date Costs in the Three Months Ended Costs in the Nine Months Ended (amounts in thousands) September 28, 2024 September 28, 2024 Restructuring severance and employee-related charges (1) $ 20,900 $ 16,094 $ 5,805 $ 13,012 Other restructuring associated costs (1) 5,600 4,625 1,885 4,201 Total cash charges 26,500 20,719 7,690 17,213 Asset-related non-cash charges (1) 600 573 — 573 Total costs $ 27,100 $ 21,292 $ 7,690 $ 17,786 Total cash outlays $ 26,500 $ 15,423 $ 5,629 $ 13,308 (1) The charges incurred in the three and nine months ended September 28, 2024 were included in restructuring and asset-related charges in the accompanying Consolidated Statement of Operations. In the third quarter of 2024, we announced plans to close two additional manufacturing facilities in Europe as part of our footprint rationalization activities. We expect to incur pre-tax restructuring expenses and other closure costs of approximately $13.7 million for the approved actions, consisting of $6.7 million in restructuring severance and employee-related charges, $1.8 million in asset-related non-cash charges and $5.2 million in other restructuring associated costs. As of September 28, 2024, we have not incurred any expenses or cash outlays related to these plans. We expect to substantially complete the facility closures by the end of 2026. In the third quarter of 2023, we announced plans to close two manufacturing facilities, located in Tijuana, Mexico and Vista, California as part of our footprint rationalization activities. As of September 28, 2024, the remaining restructuring accrual for these plans is $0.6 million and the remaining cash outlay is expected to be $0.9 million. We expect to substantially complete the facility closures by the end of 2024. Costs and cash outlays associated with the plans: North America: Tijuana, Mexico and Vista, California Total Estimated Costs Cumulative Costs to-date Costs in the Three Months Ended Costs in the Nine Months Ended (amounts in thousands) September 28, 2024 September 28, 2024 Restructuring severance and employee-related charges (1) $ 7,800 $ 7,631 $ 129 $ (182) Other restructuring associated costs (1) 2,700 2,614 69 2,013 Total cash charges 10,500 10,245 198 1,831 Asset-related charges (1) 6,600 6,628 — 2,919 Inventory and other product-related non-cash charges (2) 1,500 1,466 — — Total non-cash charges 8,100 8,094 — 2,919 Total costs $ 18,600 $ 18,339 $ 198 $ 4,750 Total cash outlays $ 10,500 $ 9,588 $ 402 $ 2,962 (1) The related charges incurred in the three and nine months ended September 28, 2024 were included in restructuring and asset-related charges in the accompanying Consolidated Statement of Operations. (2) The inventory and other product-related non-cash charges incurred during 2023 were included in Cost of Sales in the Consolidated Statement of Operations. In the third quarter of 2024, we announced to employees a restructuring plan to close a manufacturing facility in Wedowee, Alabama in a continuing effort to simplify our footprint and drive operational efficiencies. As of September 28, 2024, the remaining restructuring accrual for this plan is $1.0 million and the remaining cash outlay is expected to be $2.8 million. We expect to substantially complete the facility closure by the first quarter of 2025. North America: Wedowee, Alabama Total Estimated Costs Cumulative Costs to-date Costs in the Three Months Ended Costs in the Nine Months Ended (amounts in thousands) September 28, 2024 September 28, 2024 Restructuring severance and employee-related charges (1) $ 1,100 $ 1,087 $ 1,087 $ 1,087 Other restructuring associated costs (1) 2,000 239 239 239 Total cash charges 3,100 1,326 1,326 1,326 Asset-related non-cash charges (1) 200 — — — Total costs $ 3,300 $ 1,326 $ 1,326 $ 1,326 Total cash outlays $ 3,100 $ 311 $ 311 $ 311 (1) The related charges incurred in the three and nine months ended September 28, 2024 were included in restructuring and asset-related charges in the accompanying Consolidated Statement of Operations. In the first quarter of 2023, we announced to employees a restructuring plan to close a manufacturing facility in Atlanta, Georgia. We completed the plant closure during 2023, with total pre-tax restructuring expenses and other closure costs of approximately $17.7 million, including $1.1 million of capital expenditures, and total cash outlays of approximately $12.9 million. The primary expenses incurred were accelerated depreciation and amortization, equipment relocation costs, and restructuring severance and employee-related charges.

Held for Sale

Held for Sale	9 Months Ended
	Sep. 28, 2024
Discontinued Operations and Disposal Groups [Abstract]
Held for Sale	Discontinued Operations On April 17, 2023, we entered into a Share Sale Agreement with Aristotle Holding III Pty Limited, a subsidiary of Platinum Equity Advisors, LLC, to sell JW Australia, for a purchase price of approximately AUD $688 million. On July 2, 2023, we completed the sale, receiving net cash proceeds of approximately $446 million, including $3.3 million of cash received from the settlement of certain forward contracts. We have classified the results of operations for the JW Australia reportable segment, together with certain costs related to the sale, as discontinued operations within the consolidated statements of operations for all periods presented. Subsequent to the completion of the sale, we entered into an agreement to provide certain transition services to JW Australia, including providing information technology post-closing services, purchases under a supply agreement, and reimbursement for certain costs to upgrade specific IT systems up to a capped amount. As of September 28, 2024, we had a liability of $3.9 million relating to these matters, which was included in accrued expenses and other current liabilities in our consolidated balance sheet. As of December 31, 2023, our liability relating to these matters was $8.2 million, of which $6.1 million was included in accrued expenses and other current liabilities, and the remaining was included in deferred credits and other liabilities in the accompanying consolidated balance sheet. Components of amounts reflected in the consolidated statements of operations related to discontinued operations are presented in the table, as follows: Three Months Ended Nine Months Ended (amounts in thousands) September 30, 2023 September 30, 2023 Net revenues $ — $ 301,876 Cost of sales — 211,575 Gross margin — 90,301 Selling, general and administrative 606 62,083 Operating (loss) income (606) 28,218 Interest income, net — (685) Other income, net (17) (2,274) (Loss) income from discontinued operations before taxes (589) 31,177 Income tax (benefit) expense (1,390) 7,928 Income from discontinued operations, net of tax $ 801 $ 23,249 The cash flows related to discontinued operations have not been segregated and are included in the consolidated statements of cash flows through the divestiture date of July 2, 2023. The following table presents cash flow and non-cash information related to discontinued operations: Nine Months Ended (amounts in thousands) September 30, 2023 Depreciation and amortization $ 5,196 Capital expenditures 6,229 Share-based incentive compensation 812 Provision for bad debt 5,062 As of September 28, 2024 and December 31, 2023, the assets and liabilities associated with the court-ordered divestiture of Towanda as described further in Note 21 - C ommitments and Contingencies, qualify as held for sale. Since the Company will continue manufacturing door skins for its internal needs, the divestiture decision did not represent a strategic shift thereby precluding the divestiture as qualifying as a discontinued operation. In addition to the Towanda net assets, we own assets in Mexico, which are also classified as held for sale in the accompanying consolidated balance sheet as of September 28, 2024. Mexico had assets held for sale of $2.2 million at September 28, 2024. As of December 31, 2023, the assets and liabilities classified as held for sale are those of Towanda. As of September 28, 2024 and December 31, 2023, the related assets and liabilities included within the summary below were expected to be disposed of within the next twelve months and are included in assets held for sale and liabilities held for sale in the accompanying consolidated balance sheets. (amounts in thousands) September 28, 2024 December 31, 2023 Assets Inventories $ 16,322 $ 17,337 Other current assets 139 108 Property and equipment, net 63,385 50,672 Intangible assets, net 1,471 1,471 Goodwill 65,000 65,000 Operating lease assets, net 2,416 975 Assets held for sale $ 148,733 $ 135,563 Liabilities Accrued payroll and benefits $ 1,158 $ 901 Accrued expenses and other current liabilities 7,111 6,126 Operating lease liability 1,018 37 Liabilities held for sale $ 9,287 $ 7,064

Other Income, Net

Other Income, Net	9 Months Ended
	Sep. 28, 2024
Other Income and Expenses [Abstract]
Other Income, Net	Other Income, Net The table below summarizes the amounts included in other income, net in the accompanying consolidated statements of operations: Three Months Ended Nine Months Ended (amounts in thousands) September 28, 2024 September 30, 2023 September 28, 2024 September 30, 2023 Cash received on investment in real estate $ (3,210) $ — $ (5,737) $ — Pension expense 484 1,618 1,512 4,969 Foreign currency gains, net (311) (216) (1,145) (2,318) Income from refund of deposits for China antidumping and countervailing duties (1) (239) — (3,186) — JW Australia Transition Services Agreement cost recovery (27) (4,000) (6,569) (4,000) Insurance reimbursement — — (1,655) (1,234) Recovery of cost from receipts on impaired notes — (1,325) (1,389) (3,000) Governmental assistance — (1,257) (927) (1,448) Income from short-term investments and forward contracts related to the JW Australia divestiture — (3,109) — (3,109) Other items, net (172) (1,164) (1,130) (841) Total other income, net $ (3,475) $ (9,453) $ (20,226) $ (10,981) (1) Represents the refund of deposits for antidumping and countervailing duties on wood mouldings and millwork products purchased from China from 2020 to 2022.

Derivative Financial Instrument

Derivative Financial Instruments	9 Months Ended
	Sep. 28, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Financial Instruments	Derivative Financial Instruments Foreign currency derivatives – As a multinational corporation, we are exposed to the impact of foreign currency fluctuations. To the extent borrowings, sales, purchases, or other transactions are not executed in the local currency of the operating unit, we are exposed to foreign currency risk. In most of the countries in which we operate, the exposure to foreign currency movements is limited because the operating revenues and expenses of our business units are substantially denominated in the local currency. To mitigate the exposure, we may enter into a variety of foreign currency derivative contracts. To manage the effect of exchange fluctuations on forecasted sales, purchases, acquisitions, capital expenditures, and certain intercompany transactions that are denominated in foreign currencies, we have foreign currency derivative contracts with a total notional amount of $81.0 million as of September 28, 2024. We have foreign currency derivative contracts, with a total notional amount of $121.6 million, to manage the risks of foreign currency gains and losses on intercompany loans and interest. We do not use derivative financial instruments for trading or speculative purposes. With the exception of the AUD/USD forward contracts entered into on April 18, 2023 described below, as of September 28, 2024, we have not elected hedge accounting for any foreign currency derivative contracts. We record mark-to-market changes in the values of these derivatives in other income, net. We recorded mark-to-market losses of $0.9 million and gains of $0.6 million relating to foreign currency derivatives in the three and nine ended September 28, 2024, respectively. We recorded mark-to-market gains of $0.4 million and $0.5 million relating to foreign currency derivatives during the three and nine months ended September 30, 2023, respectively. On April 18, 2023, we entered into forward contracts to sell a total of AUD 420.0 million and receive USD at exchange rates ranging from 0.6751 USD to 0.6759 USD to 1.0 AUD to mitigate the impact of the Australian dollar currency fluctuations on our net investment in JELD-WEN Australia Pty. Ltd. We designated the forward contracts as net investment hedges. The contracts matured during the three months ended September 30, 2023 and the gain, net of forward points, was included in the gain on the sale of JW Australia. The net proceeds are included in the proceeds (payments) related to the sale of JW Australia within our consolidated statements of cash flows. No portion of these contracts were deemed ineffective during the three and nine months ended September 30, 2023. Interest rate derivatives – We are exposed to interest rate risk in connection with our variable rate long-term debt. In May 2020, we entered into interest rate swap agreements with notional amounts aggregating to $370.0 million to manage this risk. The interest rate swap agreements matured in December 2023. Initially, the agreements had a weighted average fixed rate of 0.395% swapped against one-month USD LIBOR floored at 0.00%. In June 2023, we amended the agreements to replace LIBOR with a Term SOFR based rate. The amended agreements had a weighted average fixed rate of 0.317% swapped against one-month USD-SOFR CME Term floored at (0.10)%. All other terms and conditions were unchanged. We designated the interest rate swap agreements as cash flow hedges and they effectively fixed the interest rate on a corresponding portion of the aggregate debt outstanding under our Term Loan Facility. In February 2024, we entered into interest rate collar agreements with a cap rate of 4.50% paid against one-month USD-SOFR CME Term floored at 3.982% and 3.895% with outstanding notional amounts aggregating to $100.0 million corresponding to that amount of the debt outstanding under our Term Loan Facility. The interest rate collar agreements were designated as cash flow hedges of a portion of the interest obligations on our Term Loan Facility borrowings and mature in February 2026. No portion of these interest rate contracts were deemed ineffective during the three and nine months ended September 28, 2024. In other comprehensive income, we recorded pre-tax mark-to-market losses As of September 28, 2024, approximately $0.4 million in losses is expected to be reclassified to interest income over the next 12 months. Other derivative instruments – From time to time, we enter into other types of derivative instruments immaterial to the consolidated financial statements. Unless otherwise disclosed, these instruments are not designated as hedging instruments and mark-to-market adjustments are recorded in the statement of operations each period. The fair values of derivative instruments held are as follows: Derivative assets (amounts in thousands) Balance Sheet Location September 28, 2024 December 31, 2023 Derivatives not designated as hedging instruments: Foreign currency forward contracts Other current assets $ 685 $ 1,186 Other derivative instruments Other current assets $ 36 $ 38 Derivative liabilities (amounts in thousands) Balance Sheet Location September 28, 2024 December 31, 2023 Derivatives designated as hedging instruments: Interest rate contracts Accrued expenses and other current liabilities $ 342 $ — Interest rate contracts Deferred credits and other liabilities $ 519 $ — Derivatives not designated as hedging instruments: Foreign currency forward contracts Accrued expenses and other current liabilities $ 1,828 $ 2,975 Other derivative instruments Accrued expenses and other current liabilities $ — 21

Fair Value of Financial Instrum

Fair Value of Financial Instruments	9 Months Ended
	Sep. 28, 2024
Fair Value Disclosures [Abstract]
Fair Value of Financial Instruments	Fair Value of Financial Instruments We record financial assets and liabilities at fair value based on FASB guidance related to fair value measurements. The guidance requires fair value to be determined based on the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants at the measurement date. Three levels of inputs may be used to measure fair value: Level 1 – Quoted prices in active markets for identical assets or liabilities. Level 2 – Quoted market-based inputs or unobservable inputs that are corroborated by market data. Level 3 – Unobservable inputs that are not corroborated by market data. The recorded carrying amounts and fair values of these instruments were as follows: September 28, 2024 (amounts in thousands) Carrying Amount Total Level 1 Level 2 Level 3 Assets: Cash equivalents $ 116,115 $ 116,115 $ 116,115 $ — $ — Derivative assets, recorded in other current assets 721 721 — 721 — Deferred compensation plan assets, recorded in other assets 4,963 4,963 — 4,963 — Liabilities: Debt, recorded in long-term debt and current maturities of long-term debt $ 1,219,800 $ 1,217,502 $ — $ 1,217,502 $ — Derivative liabilities, recorded in accrued expenses and other current liabilities 2,170 2,170 — 2,170 — Derivative liabilities, recorded in deferred credits and other liabilities 519 519 — 519 — December 31, 2023 (amounts in thousands) Carrying Amount Total Level 1 Level 2 Level 3 Assets: Cash equivalents $ 71,139 $ 71,139 $ 71,139 $ — $ — Derivative assets, recorded in other current assets 1,224 1,224 — 1,224 — Deferred compensation plan assets, recorded in other assets 2,098 2,098 — 2,098 — Liabilities: Debt, recorded in long-term debt and current maturities of long-term debt $ 1,232,780 $ 1,209,961 $ — $ 1,209,961 $ — Derivative liabilities, recorded in accrued expenses and other current assets 2,996 2,996 — 2,996 — Derivative assets and liabilities reported in level 2 primarily include: (1) as of September 28, 2024, foreign currency derivative contracts and interest rate collar agreements; (2) as of December 31, 2023, foreign currency derivative contracts. See Note 19 - Derivative Financial Instruments for additional information about our derivative assets and liabilities. Deferred compensation plan assets reported in level 2 consist of mutual funds. There are no material non-financial assets or liabilities as of September 28, 2024 or December 31, 2023.

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Sep. 28, 2024
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies Litigation – We are involved in various legal proceedings, claims, and government audits arising in the ordinary course of business. We record our best estimate of a loss when the loss is considered probable and the amount of such loss can be reasonably estimated. When a loss is probable and there is a range of estimated loss with no best estimate within the range, we record the minimum estimated liability related to the lawsuit or claim. As additional information becomes available, we reassess the potential liability and revise our accruals, if necessary. Because of uncertainties related to the resolution of lawsuits and claims, the ultimate outcome may differ materially from our estimates. Other than the matters described below, there were no proceedings or litigation matters involving the Company or its property as of September 28, 2024 that we believe would have a material adverse effect on our consolidated financial position or cash flows, although they could have a material adverse effect on our operating results for a particular reporting period. Steves & Sons, Inc. v JELD-WEN, Inc. – We sell molded door skins to certain customers pursuant to long-term contracts, and these customers in turn use the molded door skins to manufacture interior doors and compete directly against us in the marketplace. We gave notice of termination of one of these contracts and, on June 29, 2016, the counterparty to the agreement, Steves & Sons, Inc. (“Steves”) filed a claim against JWI in the U.S. District Court for the Eastern District of Virginia, Richmond Division (the “Eastern District of Virginia”). The complaint alleged that our acquisition of CMI, a competitor in the molded door skins market, together with subsequent price increases and other alleged acts and omissions, violated antitrust laws, and constituted a breach of contract and breach of warranty. Specifically, the complaint alleged that our acquisition of CMI substantially lessened competition in the molded door skins market. The complaint sought declaratory relief, ordinary and treble damages, and injunctive relief, including divestiture of certain assets acquired in the CMI acquisition. In February 2018, a jury in the Eastern District of Virginia returned a verdict that was unfavorable to JWI with respect to Steves’ claims that our acquisition of CMI violated Section 7 of the Clayton Act, and found that JWI breached the supply agreement between the parties (the “Original Action”). The verdict awarded Steves $12.2 million for past damages under both the Clayton Act and breach of contract claims and $46.5 million in future lost profits under the Clayton Act claim. During the course of the proceedings in the Eastern District of Virginia, we discovered certain facts that led us to conclude that Steves, its principals, and certain former employees of the Company had misappropriated Company trade secrets, violated the terms of various agreements between the Company and those parties, and violated other laws. On May 11, 2018, a jury in the Eastern District of Virginia returned a verdict on our trade secrets claims against Steves and awarded damages in the amount of $1.2 million. The presiding judge entered a judgment in our favor for those damages, and the entire amount has been paid by Steves. On August 16, 2019, the presiding judge granted Steves’ request for an injunction, prohibiting us from pursuing certain claims against individual defendants pending in Bexar County, Texas (the “Steves Texas Trade Secret Theft Action”). On September 11, 2019, JELD-WEN filed a notice of appeal of the Eastern District of Virginia’s injunction to the Fourth Circuit Court of Appeals (the “Fourth Circuit”). On March 13, 2019, the presiding judge entered an Amended Final Judgment Order in the Original Action, awarding $36.5 million in past damages under the Clayton Act (representing a trebling of the jury’s verdict) and granted divestiture of certain assets acquired in the CMI acquisition, subject to appeal. The judgment also conditionally awarded damages in the event the judgment was overturned on appeal. Specifically, the court awarded $139.4 million as future antitrust damages in the event the divestiture order was overturned on appeal and $9.9 million as past contract damages in the event both the divestiture and antitrust claims were overturned on appeal. On April 12, 2019, Steves filed a petition requesting an award of its fees and a bill of costs, seeking $28.4 million in attorneys’ fees and $1.7 million in costs in connection with the Original Action. On November 19, 2019, the presiding judge entered an order for further relief awarding Steves an additional $7.1 million in damages for pricing differences from the date of the underlying jury verdict through May 31, 2019 (the “Pricing Action”). We also appealed that ruling. On April 14, 2020, Steves filed a motion for further supplemental relief for pricing differences from the date of the prior order and going forward through the end of the parties’ current supply agreement (the “Future Pricing Action”). We opposed that request for further relief. JELD-WEN filed a supersedeas bond and notice of appeal of the judgment, which was heard by the Fourth Circuit on May 29, 2020. On February 18, 2021, the Fourth Circuit issued its decision on appeal in the Original Action, affirming the Amended Final Judgment Order in part and vacating and remanding in part. The Fourth Circuit vacated the Eastern District of Virginia’s alternative $139.4 million lost-profits award, holding that award was premature because Steves has not suffered the purported injury on which its claim for future lost profits rests. The Fourth Circuit also vacated the Eastern District of Virginia’s judgment for Sam Steves, Edward Steves, and John Pierce on JELD-WEN’s trade secrets claims. The Fourth Circuit affirmed the Eastern District of Virginia’s finding of antitrust injury and its award of $36.5 million in past antitrust damages. It also affirmed the Eastern District of Virginia’s divestiture order, while clarifying that JELD-WEN retains the right to challenge the terms of any divestiture, including whether a sale to any particular buyer will serve the public interest, and made clear that the Eastern District of Virginia may need to revisit its divestiture order if the special master who has been appointed by the presiding judge cannot locate a satisfactory buyer. JELD-WEN then filed a motion for rehearing en banc with the Fourth Circuit that was denied on March 22, 2021. On May 1, 2024, JWI filed a motion to modify the Amended Final Judgment (the “Motion”) with the Eastern District of Virginia to vacate all court orders requiring divestiture of the Company’s Towanda operations and certain related assets. In light of changed industry and market factors and conditions, the Company believes that the divestiture of Towanda is no longer warranted and is asking the court for relief from that ruling. The court is still reviewing the Motion, and the court mandated divestiture process and related court proceedings are ongoing. We made estimates related to the divestiture in the preparation of our financial statements. However, there can be no assurance that the Motion will be granted and that the divestiture requirement will be vacated, or that if the Motion is not granted, the proposed divestiture will ultimately be approved by the court. There can also be no guarantee that the divestiture will be consummated if the divestiture requirement is not ultimately vacated. Moreover, the Company cannot predict when the court will issue a final ruling on the Motion or the terms of the proposed divestiture. During the pendency of the Original Action, on February 14, 2020, Steves filed a complaint and motion for preliminary injunction in the Eastern District of Virginia alleging that we breached the long-term supply agreement between the parties, including, among other claims, by incorrectly calculating the allocation of door skins owed to Steves (the “Allocation Action”). Steves sought an additional allotment of door skins and damages for violation of antitrust laws, tortious interference, and breach of contract. On April 10, 2020, the presiding judge granted Steves’ motion for preliminary injunction, and the parties settled the issues underlying the preliminary injunction on April 30, 2020 and the Company reserved the right to appeal the ruling in the Fourth Circuit. The Company believed all the claims lacked merit and moved to dismiss the antitrust and tortious interference claims. On June 2, 2020, we entered into a settlement agreement with Steves to resolve the Pricing Action, the Future Pricing Action, and the Allocation Action. As a result of the settlement, Steves filed a notice of satisfaction of judgment in the Pricing Action, withdrew its Future Pricing Action with prejudice, and filed a stipulated dismissal with prejudice in the Allocation Action. The Company also withdrew its appeal of the Pricing Action. The parties agreed to bear their own respective attorneys’ fees and costs in these actions. In partial consideration of the settlement, JWI and Steves entered into an amended supply agreement satisfactory to both parties that, by its terms, ended on September 10, 2021. This settlement had no effect on the Original Action between the parties except to agree that certain specific terms of the Amended Final Judgment Order in the Original Action would apply to the amended supply agreement during the pendency of the appeal of the Original Action. On April 2, 2021, JWI and Steves filed a stipulation regarding the amended supply agreement in the Original Action, stating that regardless of whether the case remains on appeal as of September 10, 2021, and absent further order of the court, the amended supply agreement would be extended until the divestiture of Towanda and certain related assets is complete and Steves’ new supply agreement with the company that acquires Towanda is in effect. We continue to believe the claims in the settled actions lacked merit and made no admission of liability in these matters. On October 7, 2021, we entered into a settlement agreement with Steves to resolve the following: (i) Steves’ past and any future claims for attorneys’ fees, expenses, and costs in connection with the Original Action, except that Steves and JWI each reserved the right to seek attorneys’ fees arising out of any challenge of the divestiture process or the final divestiture order; (ii) the Steves Texas Trade Secret Theft Action and the related Fourth Circuit appeal of the Eastern District of Virginia’s injunction in the Original Action; (iii) the past damages award in the Original Action; and (iv) any and all claims and counterclaims, known or unknown, that were asserted or could have been asserted against each other from the beginning of time through the date of the settlement agreement. As a result of the settlement, the parties filed a stipulated notice of satisfaction of the past antitrust damages judgment and a stipulated notice of settlement of Steves’ claim for attorneys’ fees, expenses, and costs against JWI in the Original Action, and Steves filed a notice of withdrawal of its motion for attorneys’ fees and expenses and bill of costs in the Original Action. The Company also filed a notice of dismissal with prejudice and agreed to take no judgment in the Steves Texas Trade Secret Theft Action, and the parties filed a joint agreement for dismissal of the injunction appeal in the Fourth Circuit. On November 3, 2021, we paid $66.4 million to Steves under the settlement agreement. In re JELD-WEN Holding, Inc. Derivative Litigation – On February 2, 2021, Jason Aldridge, on behalf of the Company, filed a derivative action in the U.S. District Court for the District of Delaware against certain current and former executives and directors of the Company, alleging that the individual defendants breached their fiduciary duties by allowing the wrongful acts alleged in the Steves and Cambridge actions, as well as violations of Section 14(a) and 20(a) of the Exchange Act, unjust enrichment, and waste of corporate assets among other allegations (the “Aldridge Action”). The lawsuit sought compensatory damages, equitable relief, and an award of attorneys’ fees and costs. The plaintiff filed an amended complaint on May 10, 2021. On June 21, 2021, prior to a response from the Company in the Aldridge Action, Shieta Black and the Board of Trustees of the City of Miami General Employees’ & Sanitation Employees’ Retirement Trust, on behalf of the Company, filed a derivative action in the U.S. District Court for the District of Delaware against certain current and former executives and directors of the Company and Onex Corporation (“Onex”), alleging that the defendants breached their fiduciary duties by allowing the wrongful acts alleged in the Steves and Cambridge actions, as well as insider trading, and unjust enrichment among other allegations (the “Black Action”). The lawsuit sought compensatory damages, corporate governance reforms, restitution, equitable relief, and an award of attorneys’ fees and costs. The court granted the Black and Aldridge plaintiffs in motion to consolidate the lawsuits on July 16, 2021. On June 20, 2022, the parties entered into a settlement agreement of the consolidated matters, which was approved by the Court on approval of the December 20, 2022, and the cases were dismissed with prejudice. In January 2023, the Company, as putative plaintiff, received approximately $10.5 million after attorneys’ fees and costs were deducted as part of the settlement. Canadian Antitrust Litigation – On May 15, 2020, Développement Émeraude Inc., on behalf of itself and others similarly situated, filed a putative class action lawsuit against the Company and Masonite in the Superior Court of the Province of Quebec, Canada, which was served on us on September 18, 2020 (“the Quebec Action”). The putative class consists of any person in Canada who, since October 2012, purchased one or more interior molded doors from the Company or Masonite. The suit alleges an illegal conspiracy between the Company and Masonite to agree on prices, the distribution of market shares and/or the production levels of interior molded doors and that the plaintiffs suffered damages in that they were charged and paid higher prices for interior molded doors than they would have had to pay but for the alleged anti-competitive conduct. The plaintiffs are seeking compensatory and punitive damages, attorneys’ fees and costs. On September 9, 2020, Kate O’Leary Swinkels, on behalf of herself and others similarly situated, filed a putative class action against the Company and Masonite in the Federal Court of Canada, which was served on us on September 29, 2020 (the “Federal Court Action”). The Federal Court Action makes substantially similar allegations to the Quebec Action and the putative class is represented by the same counsel. In February 2021, the plaintiff in the Federal Court Action issued a proposed Amended Statement of Claim that replaced the named plaintiff, Kate O’Leary Swinkels, with David Regan. The plaintiff has sought a stay of the Quebec Action while the Federal Court Action proceeds. On July 14, 2023, the Company entered into an agreement in principle with class counsel to resolve both actions for an immaterial amount, which the Company recorded in the second quarter of 2023. A formal settlement agreement was executed as of March 27, 2024 and remains subject to court approval. The Company continues to believe the plaintiffs’ claims lack merit and denies any liability or wrongdoing for the claims made against the Company. We have evaluated the claims against us and recorded provisions based on management’s judgment about the probable outcome of the litigation and have included our estimates in accrued expenses in the accompanying balance sheets. See Note 8 - Accrued Expenses and Other Current Liabilities . While we expect a favorable resolution to these matters, the dispute resolution process could be lengthy, and if the plaintiffs were to prevail completely or substantially in the respective matters described above, such an outcome could have a material adverse effect on our operating results, consolidated financial position, or cash flows. Self-Insured Risk – We self-insure substantially all of our domestic business liability risks including general liability, product liability, warranty, personal injury, auto liability, workers’ compensation, and employee medical benefits. Excess insurance policies from independent insurance companies generally cover exposures between $5.0 million and $200.0 million for domestic product liability risk and exposures between $3.0 million and $200.0 million for auto, general liability, personal injury, and workers’ compensation. We estimate our provision for self-insured losses based upon an evaluation of current claim exposure and historical loss experience. Actual self-insurance losses may vary significantly from these estimates. At September 28, 2024 and December 31, 2023, our accrued liability for self-insured risks was $83.2 million and $89.2 million, respectively. Indemnifications – At September 28, 2024, we had commitments related to certain representations made in contracts for sale of businesses or property, including the divestiture of JW Australia. Our indemnity obligations under the relevant agreements may be limited in terms of time, amount or scope. These representations primarily relate to past actions such as responsibility for transfer taxes if they should be claimed, and the adequacy of recorded liabilities, warranty matters, employment benefit plans, income tax matters, or environmental exposures. As it relates to certain income tax related liabilities, the relevant agreements may not provide any cap for such liabilities, and the period in which we would be liable would lapse upon expiration of the statute of limitation for assessment of the underlying taxes. Because of the conditional nature of these obligations and the unique facts and circumstances involved in each particular agreement, we are unable to reasonably estimate the potential maximum exposure associated with these items. We are not aware of any material amounts claimed or expected to be claimed under these indemnities. From time to time and in limited geographic areas, we have entered into agreements for the sale of our products to certain customers that provide additional indemnifications for liabilities arising from construction or product defects. We cannot estimate the potential magnitude of such exposures, but to the extent specific liabilities have been identified related to product sales, liabilities have been provided in the warranty accrual in the accompanying consolidated balance sheets. Other Financing Arrangements – At times we are required to provide letters of credit, surety bonds, or guarantees to meet various performance, legal, warranty, environmental, workers compensation, licensing, utility, and governmental requirements. Stand-by letters of credit are provided to certain customers and counterparties in the ordinary course of business as credit support for contractual performance guarantees, advanced payments received from customers, and future funding commitments. The stated values of these letters of credit agreements, surety bonds, and guarantees were $71.6 million at September 28, 2024 and $68.7 million at December 31, 2023, respectively. Environmental Contingencies – We periodically incur environmental liabilities associated with remediating our current and former manufacturing sites as well as penalties for not complying with environmental rules and regulations. We record a liability for remediation costs when it is probable that we will be responsible for such costs and the costs can be reasonably estimated. These environmental liabilities are estimated based on current available facts and current laws and regulations. Accordingly, it is likely that adjustments to the estimated liabilities will be necessary as additional information becomes available. Short-term environmental liabilities and settlements are recorded in accrued expenses and other current liabilities deferred credits and other liabilities Everett, Washington WADOE Action – In 2007, we were identified by the WADOE as a PLP with respect to our former manufacturing site in Everett, Washington. In 2008, we entered into an Agreed Order with the WADOE to assess historic environmental contamination and remediation feasibility at the site. As part of the order, we agreed to develop a CAP, arising from the feasibility assessment. In December 2020, we submitted to the WADOE a draft feasibility assessment with an array of remedial alternatives, which we considered substantially complete. During 2021, several comment rounds were completed as well as the identification of the Port of Everett and W&W Everett Investment LLC as additional PLPs, with respect to this matter with each PLP being jointly and severally liable for the cleanup costs. The WADOE received the final feasibility assessment on December 31, 2021, containing various remedial alternatives with its preferred remedial alternatives totaling $23.4 million. Based on this study, we have determined our range of possible outcomes to be $11.8 million to $33.4 million. On March 1, 2022, we delivered a draft CAP consistent with the preferred alternatives which was approved by WADOE in August 2023. The existing Agreed Order of 2008 was also modified with WADOE in July 2023 to support the development of the associated CAP investigation, sampling and design components. We have made provisions within our financial statements within the range of possible outcomes; however, the contents and cost of the final CAP and allocation of the responsibility between the identified PLPs could vary materially from our estimates. Towanda, Pennsylvania Consent Order – In December 2020, we entered into a COA with the PaDEP to remove a pile of wood fiber waste from our site in Towanda, Pennsylvania, which we acquired in connection with our acquisition of CMI in 2012, by using it as fuel for a boiler at that site. The COA replaced a 2018 Consent Decree between the Company and PaDEP. Under the COA, we are required to achieve certain periodic removal objectives and ultimately remove the entire pile by August 31, 2025. As of September 28, 2024 and December 31, 2023 there was $1.4 million, respectively in bonds posted in connection with these obligations. If we are unable to remove this pile by August 31, 2025, then the bonds will be forfeited, and we may be subject to penalties by PaDEP. We currently anticipate meeting all applicable removal deadlines; however, if our operations should change, additional alternatives would be evaluated to meet the prescribed removal timeline.

Supplemental Cash Flow Informat

Supplemental Cash Flow Information	9 Months Ended
	Sep. 28, 2024
Supplemental Cash Flow Elements [Abstract]
Supplemental Cash Flow Information	Supplemental Cash Flow Information Nine Months Ended (amounts in thousands) September 28, 2024 September 30, 2023 Cash Operating Activities: Operating leases $ 35,397 $ 46,033 Interest payments on financing lease obligations 377 217 Cash paid for amounts included in the measurement of lease liabilities $ 35,774 $ 46,250 Cash Investing Activities: Purchases of securities for deferred compensation plan $ (3,113) $ (1,020) Sale of securities for deferred compensation plan — 127 Change in securities for deferred compensation plan $ (3,113) $ (893) Cash received on notes receivable 31 — Change in notes receivable $ 31 $ — Non-cash Investing Activities: Property, equipment, and intangibles purchased in accounts payable $ 13,378 $ 5,422 Property, equipment, and intangibles purchased with debt 7,272 10,984 Customer accounts receivable converted to notes receivable 393 193 Consideration receivable from sale of business 2,000 — Cash Financing Activities: Borrowings on long-term debt $ 351,225 $ 127,317 Payments of long-term debt (371,536) (672,755) Payments of debt issuance and extinguishment costs, including underwriting fees (5,284) (3,908) Change in long-term debt and payments of debt extinguishment costs $ (25,595) $ (549,346) Cash paid for amounts included in the measurement of finance lease liabilities $ 1,865 $ 1,351 Non-cash Financing Activities: Prepaid insurance funded through short-term debt borrowings $ — $ 16,628 Accounts payable converted to installment notes 5 176 Other Supplemental Cash Flow Information: Cash taxes paid, net of refunds $ 29,575 $ 41,988 Cash interest paid 49,469 53,442

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 28, 2024	Sep. 30, 2023	Sep. 28, 2024	Sep. 30, 2023
Pay vs Performance Disclosure
Net (loss) income	$ (74,402)	$ 43,785	$ (120,623)	$ 97,200

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended
	Sep. 28, 2024
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

Description of Company and Su_2

Description of Company and Summary of Significant Accounting Policies (Policies)	9 Months Ended
	Sep. 28, 2024
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation – The accompanying unaudited consolidated financial statements as of September 28, 2024 and for the three and nine months ended September 28, 2024 and September 30, 2023, respectively, have been prepared in accordance with GAAP for interim financial information and pursuant to the rules and regulations of the SEC. In the opinion of management, the unaudited consolidated financial statements have been prepared on the same basis as the audited financial statements and include all adjustments, consisting only of normal recurring adjustments, necessary for the fair statement of the Company’s financial position for the periods presented. The results for the three and nine months ended September 28, 2024 are not necessarily indicative of the results to be expected for the year ending December 31, 2024, or any other period. The accompanying consolidated balance sheet as of December 31, 2023 was derived from audited financial statements included in our Annual Report on Form 10-K. The accompanying consolidated financial statements do not include all of the information and footnotes required by GAAP for annual financial statements. Accordingly, they should be read in conjunction with the audited financial statements and notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2023. On April 17, 2023, we entered into a Share Sale Agreement with Aristotle Holding III Pty Limited, a subsidiary of Platinum Equity Advisors, LLC, to sell JW Australia. On July 2, 2023, we completed the sale. The net assets and operations of the disposal group met the criteria to be classified as “discontinued operations” and are reported as such in all periods presented unless otherwise noted. The consolidated statements of cash flows include cash flows from discontinued operations through the divestiture date of July 2, 2023. See Note 2 - Discontinued Operations for further information. All U.S. dollar and other currency amounts, except per share amounts, are presented in thousands unless otherwise noted.
Fiscal Year	Fiscal Year – We operate on a fiscal calendar year, and each interim quarter is comprised of two 4-week periods and one 5-week period, with each week ending on a Saturday. Our fiscal year always begins on January 1 and ends on December 31. As a result, our first and fourth quarters may have more or fewer days included than a traditional 91-day fiscal quarter.
Use of Estimates	Use of Estimates – The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates, assumptions, and allocations that affect amounts reported in the consolidated financial statements and related notes. Significant items that are subject to such estimates and assumptions include, but are not limited to, long-lived assets including goodwill and other intangible assets, employee benefit obligations, income tax uncertainties, contingent assets and liabilities, provisions for bad debt, inventory, warranty liabilities, legal claims, valuation of derivatives, environmental remediation, and claims relating to self-insurance. Actual results could differ due to the uncertainty inherent in the nature of these estimates.
Recent Accounting Standards Not Yet Adopted	Recent Accounting Standards Not Yet Adopted – In November 2023, the FASB issued ASU 2023-07, Improvements to Reportable Segment Disclosures . ASU 2023-07 requires disclosure of significant segment expenses that are regularly provided to the CODM and included within the segment measure of profit or loss, an amount and description of its composition for other segment items to reconcile to segment profit or loss, and the title and position of the entity’s CODM. ASU 2023-07 will be applied retrospectively and is effective for annual reporting periods in fiscal years beginning after December 15, 2023, and interim reporting periods in fiscal years beginning after December 31, 2024. We do not expect the guidance to have an impact on our financial positions and results of operations. We are currently evaluating the impact of this guidance on the Company’s disclosures. In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures . ASU 2023-09 expands disclosures in an entity’s income tax rate reconciliation table and regarding cash taxes paid both in the U.S. and foreign jurisdictions. The guidance is effective for annual periods beginning after December 15, 2024, with early adoption permitted, and should be applied either prospectively or retrospectively. We have not elected to early adopt this standard. We do not expect the guidance to have an impact on our financial positions and results of operations. We are currently evaluating the impact of this guidance on the Company’s disclosures. We have considered the applicability and impact of all ASUs. We have assessed ASUs not listed above and have determined that they were either not applicable or were not expected to have a material impact on our financial statements.

Discontinued Operations (Tables

Discontinued Operations (Tables)	9 Months Ended
	Sep. 28, 2024
Discontinued Operations and Disposal Groups [Abstract]
Schedule of Discontinued Operations	Components of amounts reflected in the consolidated statements of operations related to discontinued operations are presented in the table, as follows: Three Months Ended Nine Months Ended (amounts in thousands) September 30, 2023 September 30, 2023 Net revenues $ — $ 301,876 Cost of sales — 211,575 Gross margin — 90,301 Selling, general and administrative 606 62,083 Operating (loss) income (606) 28,218 Interest income, net — (685) Other income, net (17) (2,274) (Loss) income from discontinued operations before taxes (589) 31,177 Income tax (benefit) expense (1,390) 7,928 Income from discontinued operations, net of tax $ 801 $ 23,249 The cash flows related to discontinued operations have not been segregated and are included in the consolidated statements of cash flows through the divestiture date of July 2, 2023. The following table presents cash flow and non-cash information related to discontinued operations: Nine Months Ended (amounts in thousands) September 30, 2023 Depreciation and amortization $ 5,196 Capital expenditures 6,229 Share-based incentive compensation 812 Provision for bad debt 5,062 As of September 28, 2024 and December 31, 2023, the related assets and liabilities included within the summary below were expected to be disposed of within the next twelve months and are included in assets held for sale and liabilities held for sale in the accompanying consolidated balance sheets. (amounts in thousands) September 28, 2024 December 31, 2023 Assets Inventories $ 16,322 $ 17,337 Other current assets 139 108 Property and equipment, net 63,385 50,672 Intangible assets, net 1,471 1,471 Goodwill 65,000 65,000 Operating lease assets, net 2,416 975 Assets held for sale $ 148,733 $ 135,563 Liabilities Accrued payroll and benefits $ 1,158 $ 901 Accrued expenses and other current liabilities 7,111 6,126 Operating lease liability 1,018 37 Liabilities held for sale $ 9,287 $ 7,064

Inventories (Tables)

Inventories (Tables)	9 Months Ended
	Sep. 28, 2024
Inventory Disclosure [Abstract]
Schedule of Inventories	Inventories are stated at the lower of cost or net realizable value. Finished goods and work-in-process inventories include material, labor, and manufacturing overhead costs. (amounts in thousands) September 28, 2024 December 31, 2023 Raw materials $ 392,836 $ 404,360 Work in process 22,928 21,141 Finished goods 88,920 84,954 Inventory valuation reserves (23,008) (29,004) Total inventories $ 481,676 $ 481,451

Property and Equipment, Net (Ta

Property and Equipment, Net (Tables)	9 Months Ended
	Sep. 28, 2024
Property, Plant and Equipment [Abstract]
Schedule of Property, Plant and Equipment	(amounts in thousands) September 28, 2024 December 31, 2023 Property and equipment $ 2,005,861 $ 1,966,371 Accumulated depreciation (1,335,071) (1,322,129) Total property and equipment, net $ 670,790 $ 644,242 Depreciation expense was recorded as follows: Three Months Ended Nine Months Ended (amounts in thousands) September 28, 2024 September 30, 2023 September 28, 2024 September 30, 2023 Cost of sales $ 20,628 $ 19,315 $ 61,090 $ 69,843 Selling, general and administrative 1,192 1,379 3,440 4,267 Total depreciation expense $ 21,820 $ 20,694 $ 64,530 $ 74,110

Goodwill (Tables)

Goodwill (Tables)	9 Months Ended
	Sep. 28, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Goodwill	The following table summarizes the changes in goodwill by reportable segment: (amounts in thousands) North Europe Total Gross carrying amount at December 31, 2023 $ 182,412 $ 268,512 $ 450,924 Sale of business (900) — (900) Foreign currency translation (114) 1,536 1,422 Gross carrying amount at September 28, 2024 $ 181,398 $ 270,048 $ 451,446 Accumulated impairment losses at December 31, 2023 $ — $ (60,754) $ (60,754) Impairment — (63,445) (63,445) Foreign currency translation — (841) (841) Accumulated impairment losses at September 28, 2024 $ — $ (125,040) $ (125,040) Balance, net of impairment at September 28, 2024 $ 181,398 $ 145,008 $ 326,406

Intangible Assets, Net (Tables)

Intangible Assets, Net (Tables)	9 Months Ended
	Sep. 28, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Finite-Lived Intangible Assets	The cost and accumulated amortization values of our intangible assets were as follows: September 28, 2024 (amounts in thousands) Cost Accumulated Net Customer relationships and agreements $ 124,094 $ (91,655) $ 32,439 Software 72,067 (28,647) 43,420 Trademarks and trade names 32,204 (12,089) 20,115 Patents, licenses and rights 12,673 (5,327) 7,346 Total amortizable intangibles $ 241,038 $ (137,718) $ 103,320 December 31, 2023 (amounts in thousands) Cost Accumulated Net Customer relationships and agreements $ 123,713 $ (84,281) $ 39,432 Software 113,429 (58,424) 55,005 Trademarks and trade names 32,148 (10,802) 21,346 Patents, licenses and rights 12,666 (4,539) 8,127 Total amortizable intangibles $ 281,956 $ (158,046) $ 123,910
Schedule of Finite-lived Intangible Assets Amortization Expense	Amortization expense was recorded as follows: Three Months Ended Nine Months Ended (amounts in thousands) September 28, 2024 September 30, 2023 September 28, 2024 September 30, 2023 Amortization expense $ 4,713 $ 9,166 $ 28,536 $ 21,166

Accrued Expenses and Other Cu_2

Accrued Expenses and Other Current Liabilities (Tables)	9 Months Ended
	Sep. 28, 2024
Payables and Accruals [Abstract]
Schedule of Accrued Expenses and Other Current Liabilities	(amounts in thousands) September 28, 2024 December 31, 2023 Accrued sales and advertising rebates $ 75,908 $ 82,732 Current portion of operating lease liability 35,327 32,477 Non-income related taxes 26,348 20,072 Current portion of warranty liability (Note 9) 18,126 22,819 Accrued freight 16,192 18,963 Current portion of accrued claim costs relating to self-insurance programs 15,509 14,079 Accrued expenses 14,779 15,758 Current portion of restructuring accrual ( Note 16 ) 14,614 3,375 Accrued interest payable 10,989 1,401 Legal claims provision ( Note 21 ) 8,228 2,683 Current portion of UTPs (Note 11) 6,864 — Deferred revenue and customer deposits 6,764 7,189 Current portion of derivative liability (Note 19) 2,170 2,996 Accrued income taxes payable 1,309 9,252 Total accrued expenses and other current liabilities $ 253,127 $ 233,796

Warranty Liability (Tables)

Warranty Liability (Tables)	9 Months Ended
	Sep. 28, 2024
Product Warranties Disclosures [Abstract]
Schedule of Analysis of Warranty Liability	An analysis of our warranty liability is as follows: (amounts in thousands) September 28, 2024 September 30, 2023 Balance as of January 1 $ 53,247 $ 52,389 Current period charges 14,741 23,930 Experience adjustments 633 (992) Payments (21,792) (22,925) Currency translation (64) (101) Balance at period end 46,765 52,301 Current portion (18,126) (22,034) Long-term portion $ 28,639 $ 30,267

Long-Term Debt (Tables)

Long-Term Debt (Tables)	9 Months Ended
	Sep. 28, 2024
Debt Disclosure [Abstract]
Schedule of Long-Term Debt Instruments	Our long-term debt, net of original issue discount and unamortized debt issuance costs, consisted of the following: September 28, 2024 September 28, 2024 December 31, 2023 (amounts in thousands) Interest Rate Senior Notes 4.88% - 7.00% $ 750,000 $ 600,000 Term Loan Facility 7.36% (1) 383,569 536,250 Finance leases and other financing arrangements 1.00% - 8.95% (1) 64,884 74,460 Mortgage notes 5.44% - 5.94% (1) 21,347 22,070 Total Debt 1,219,800 1,232,780 Unamortized debt issuance costs and original issue discounts (9,063) (6,528) Current maturities of long-term debt (30,854) (36,177) Long-term debt $ 1,179,883 $ 1,190,075 (1)

Segment Information (Tables)

Segment Information (Tables)	9 Months Ended
	Sep. 28, 2024
Segment Reporting [Abstract]
Schedule of Segment Reportable Segments, by Segment	The following tables set forth certain information relating to our segments’ operations: (amounts in thousands) North Europe Corporate Total Three Months Ended September 28, 2024 Total net revenues $ 677,992 $ 259,384 $ — $ 937,376 Intersegment net revenues (47) (2,613) — (2,660) Net revenues from external customers $ 677,945 $ 256,771 $ — $ 934,716 Three Months Ended September 30, 2023 Total net revenues $ 790,327 $ 289,692 $ — $ 1,080,019 Intersegment net revenues (42) (2,997) — (3,039) Net revenues from external customers $ 790,285 $ 286,695 $ — $ 1,076,980 (amounts in thousands) North Europe Corporate Total Nine Months Ended September 28, 2024 Total net revenues $ 2,068,645 $ 816,263 $ — $ 2,884,908 Intersegment net revenues (107) (4,943) — (5,050) Net revenues from external customers $ 2,068,538 $ 811,320 $ — $ 2,879,858 Nine Months Ended September 30, 2023 Total net revenues $ 2,375,633 $ 911,875 $ — $ 3,287,508 Intersegment net revenues (203) (4,036) — (4,239) Net revenues from external customers $ 2,375,430 $ 907,839 $ — $ 3,283,269 Three Months Ended September 28, 2024 (amounts in thousands) North America Europe Corporate and Unallocated Costs Total Consolidated Income (loss) from continuing operations, net of tax $ 35,781 $ (66,662) $ (42,081) $ (72,962) Income tax expense (benefit) 6,455 2,626 (1,830) 7,251 Depreciation and amortization 18,142 7,884 1,848 27,874 Interest expense (income), net 819 (14) 15,514 16,319 Special items: Net legal and professional expenses and settlements 619 995 10,662 12,276 Goodwill impairment — 63,445 — 63,445 Restructuring and asset-related charges 17,124 7,786 630 25,540 M&A related costs — — 3,045 3,045 Net (gain) loss on sale of business, property, and equipment (5,288) 33 (166) (5,421) Loss on extinguishment and refinancing of debt — — 459 459 Share-based compensation expense 349 346 1,764 2,459 Non-cash foreign exchange transaction/translation loss (gain) 53 (475) 59 (363) Other special items 734 291 696 1,721 Adjusted EBITDA from continuing operations $ 74,788 $ 16,255 $ (9,400) $ 81,643 Three Months Ended September 30, 2023 (amounts in thousands) North America Europe Corporate and Unallocated Costs Total Consolidated Income (loss) from continuing operations, net of tax $ 40,469 $ 10,672 $ (34,233) $ 16,908 Income tax expense (benefit) 27,412 5,974 (15,987) 17,399 Depreciation and amortization (1) 17,128 7,482 6,341 30,951 Interest expense, net 604 147 15,986 16,737 Special items: Net legal and professional expenses and settlements 802 1,264 5,335 7,401 Restructuring and asset-related charges 11,890 838 (30) 12,698 M&A related costs 84 — 1,118 1,202 Net loss (gain) on sale property and equipment 748 (4,791) 3 (4,040) Loss on extinguishment and refinancing of debt — — 6,487 6,487 Share-based compensation expense 914 455 2,013 3,382 Non-cash foreign exchange transaction/translation loss (gain) 131 2,343 (2,203) 271 Other special items (220) 67 (3,502) (3,655) Adjusted EBITDA from continuing operations $ 99,962 $ 24,451 $ (18,672) $ 105,741 (1) Corporate and unallocated depreciation and amortization expense includes software accelerated amortization of $3.5 million for an ERP that we are no longer utilizing after we completed our related obligations under the JW Australia Transition Services Agreement during the first quarter of 2024. To conform with current period presentation, certain amounts in prior period information have been reclassified. Nine Months Ended September 28, 2024 (amounts in thousands) North America Europe Corporate and Unallocated Costs Total Consolidated Income (loss) from continuing operations, net of tax $ 82,783 $ (71,665) $ (130,301) $ (119,183) Income tax expense (benefit) 26,800 15,784 (29,201) 13,383 Depreciation and amortization (1) 55,033 22,940 19,579 97,552 Interest expense, net 2,137 917 45,521 48,575 Special items: Net legal and professional expenses and settlements 2,336 2,367 45,109 49,812 Goodwill impairment — 63,445 — 63,445 Restructuring and asset-related charges 40,249 18,411 1,386 60,046 M&A related costs — — 9,223 9,223 Net gain on sale of business, property, and equipment (7,839) (153) (184) (8,176) Loss on extinguishment and refinancing of debt — — 1,908 1,908 Share-based compensation expense 2,610 994 8,988 12,592 Non-cash foreign exchange transaction/translation loss (gain) 315 (3,771) 355 (3,101) Other special items 7,199 1,911 4 9,114 Adjusted EBITDA from continuing operations $ 211,623 $ 51,180 $ (27,613) $ 235,190 (1) Corporate and unallocated depreciation and amortization expense includes software accelerated amortization of $14.1 million for an ERP that we are no longer utilizing after we completed our related obligations under the JW Australia Transition Services Agreement during the first quarter of 2024. Nine Months Ended September 30, 2023 (amounts in thousands) North America Europe Corporate and Unallocated Costs Total Consolidated Income (loss) from continuing operations, net of tax $ 126,987 $ 28,627 $ (107,739) $ 47,875 Income tax expense (benefit) 63,072 10,469 (41,903) 31,638 Depreciation and amortization (1) 62,625 22,414 12,469 97,508 Interest expense, net 4,188 692 54,203 59,083 Special items: Net legal and professional expenses and settlements 804 3,720 9,085 13,609 Restructuring and asset-related charges 25,360 2,620 796 28,776 M&A related costs 651 — 4,520 5,171 Net loss (gain) on sale of property and equipment 1,132 (5,088) 3 (3,953) Loss on extinguishment and refinancing of debt — — 6,487 6,487 Share-based compensation expense 3,366 1,438 7,451 12,255 Non-cash foreign exchange transaction/translation (gain) loss (168) 1,192 (1,921) (897) Other special items (39) (134) (3,450) (3,623) Adjusted EBITDA from continuing operations $ 287,978 $ 65,950 $ (59,999) $ 293,929 (1) Corporate and unallocated depreciation and amortization expense includes software accelerated amortization of $3.5 million for an ERP that we are no longer utilizing after we completed our related obligations under the JW Australia Transition Services Agreement during the first quarter of 2024. North America depreciation and amortization expense includes accelerated depreciation of $9.1 million from reviews of equipment capacity optimization. To conform with current period presentation, certain amounts in prior period information have been reclassified.
Schedule of Reconciliation of Net Income (Loss) to Adjusted EBITDA	Reconciliations of income from continuing operations, net of tax to Adjusted EBITDA from continuing operations are as follows: Three Months Ended Nine Months Ended (amounts in thousands) September 28, 2024 September 30, 2023 September 28, 2024 September 30, 2023 (Loss) income from continuing operations, net of tax $ (72,962) $ 16,908 (119,183) 47,875 Income tax expense 7,251 17,399 13,383 31,638 Depreciation and amortization (1) 27,874 30,951 97,552 97,508 Interest expense, net 16,319 16,737 48,575 59,083 Special items: Net legal and professional expenses and settlements (2) 12,276 7,401 49,812 13,609 Goodwill impairment (3) 63,445 — 63,445 — Restructuring and asset-related charges (4)(5) 25,540 12,698 60,046 28,776 M&A related costs (6) 3,045 1,202 9,223 5,171 Net gain on sale of business, property, and equipment (7) (5,421) (4,040) (8,176) (3,953) Loss on extinguishment and refinancing of debt (8) 459 6,487 1,908 6,487 Share-based compensation expense (9) 2,459 3,382 12,592 12,255 Non-cash foreign exchange transaction/translation (gain) loss (10) (363) 271 (3,101) (897) Other special items (11) 1,721 (3,655) 9,114 (3,623) Adjusted EBITDA from continuing operations $ 81,643 $ 105,741 $ 235,190 $ 293,929 (1) Depreciation and amortization expense includes accelerated amortization of $14.1 million in the nine months ended September 28, 2024 and $3.5 million in the three and nine months ended September 30, 2023 in Corporate and unallocated costs for an ERP that we are no longer utilizing after we completed our related obligations under the JW Australia Transition Services Agreement during the first quarter of 2024. In addition, depreciation and amortization expense in the nine months ended September 30, 2023 includes accelerated depreciation of $9.1 million in North America from reviews of equipment capacity optimization. (2) Net legal and professional expenses and settlements include non-recurring transformation journey expenses of $12.0 million and $46.6 million in the three and nine months ended September 28, 2024, respectively, and $7.1 million and $12.0 million in the three and nine months ended September 30, 2023, respectively. These expenses primarily relate to the engagement of one transformation consultant for a period spanning from the third quarter of 2023 through the fourth quarter of 2024, for which we incurred $7.0 million and $35.4 million in the three and nine months ended September 28, 2024, respectively, and $5.8 million and $6.2 million in the three and nine months ended September 30, 2023, respectively. Additionally, net legal and professional expenses and settlements include amounts relating to litigation of historic legal matters of $0.2 million and $2.8 million in the three and nine months ended September 28, 2024, respectively, and of $0.2 million and $1.6 million and in the three and nine months ended September 30, 2023, respectively. (3) Goodwill impairment consists of goodwill impairment charges associated with our Europe reporting unit. (4) Represents severance, accelerated depreciation and amortization, equipment relocation and other expenses directly incurred as a result of restructuring events. The restructuring charges primarily relate to charges incurred to change the operating structure, eliminate certain roles, and close certain manufacturing facilities in our North America and Europe segments. (5) For the three and nine months ended September 28, 2024, $1.4 million and $7.8 million, respectively, of product and inventory-related charges related to announced facility closures were detrimental to Adjusted EBITDA. (6) M&A related costs consists primarily of legal and professional expenses related to the potential disposition of Towanda. (7) Net gain on sale of business, property, and equipment in the three months ended September 28, 2024 primarily relates to the sale of our St. Kitts business. Net gain on sale of business, property, and equipment in the nine months ended September 28, 2024 primarily relates to the sale of our business in St. Kitts and property in Chile. Net gain on sale of business, property and equipment in the three and nine months ended September 30, 2023 primarily relates to the sale of a building in Melton, UK. (8) Loss on extinguishment and refinancing of debt of $0.5 million in the three months ended September 28, 2024 is related to the redemption of the remaining $200.0 million of our 4.63% Senior Notes. Loss on extinguishment and refinancing of debt of $1.9 million in the nine months ended September 28, 2024 associated with an amendment of our Term Loan Facility and redemption of the remaining $200.0 million of our 4.63% Senior Notes. Loss on extinguishment and refinancing of debt of $6.5 million in the three and nine months ended September 30, 2023 is related to the redemption of $250.0 million of our 6.25% Senior Secured Notes and $200.0 million of our 4.63% Senior Notes. (9) Represents non-cash equity-based compensation expense related to the issuance of share-based awards. (10) Non-cash foreign exchange transaction/translation gain primarily associated with fair value adjustments of foreign currency derivatives and revaluation of balances denominated in foreign currencies. (11) Other special items not core to ongoing business activity include: (i) in the three months ended September 30, 2023, ($3.1) million in income from short-term investments and forward contracts related to the JW Australia divestiture; (ii) in the nine months ended September 28, 2024, a loss of $4.3 million of cumulative foreign currency translation adjustments related to the substantial liquidation of a foreign subsidiary in Chile in our North America segment, a one-time realized foreign currency loss of $1.6 million in our Europe segment related to a cash repatriation event, and ($1.5) million of cash received on an impaired note in Corporate and unallocated costs; and (iii) in the nine months ended September 30, 2023, ($3.1) million in income from short-term investments and forward contracts related to the JW Australia divestiture. To conform with current period presentation, certain amounts in prior period information have been reclassified.

Earnings Per Share (Tables)

Earnings Per Share (Tables)	9 Months Ended
	Sep. 28, 2024
Earnings Per Share [Abstract]
Schedule of Weighted Average Shares Outstanding, Basic and Diluted	The basic and diluted income per share calculations were determined based on the following share data : Three Months Ended Nine Months Ended September 28, 2024 September 30, 2023 September 28, 2024 September 30, 2023 Weighted average outstanding shares of Common Stock basic 84,554,174 85,182,678 85,115,070 84,915,519 Restricted stock units, performance share units and options to purchase Common Stock — 1,167,162 — 813,617 Weighted average outstanding shares of Common Stock diluted 84,554,174 86,349,840 85,115,070 85,729,136
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share	The following table provides the securities that could potentially dilute basic earnings per share in the future but were not included in the computation of diluted income per share as their inclusion would be anti-dilutive: Three Months Ended Nine Months Ended September 28, 2024 September 30, 2023 September 28, 2024 September 30, 2023 Common Stock options 1,209,341 1,384,007 1,243,831 1,678,769 Restricted stock units 951,656 18,161 1,087,802 41,552 Performance share units 296,521 25,774 276,400 229,841

Stock Compensation (Tables)

Stock Compensation (Tables)	9 Months Ended
	Sep. 28, 2024
Share-Based Payment Arrangement [Abstract]
Schedule of Stock Option Activity Roll forward	The activity under our incentive plans for the periods presented are reflected in the following tables: Three Months Ended September 28, 2024 September 30, 2023 Shares Weighted Average Exercise Price Per Share Shares Weighted Average Exercise Price Per Share Options granted 9,900 $ 12.97 — $ — Options cancelled 207,958 $ 21.66 199,395 $ 21.18 Options exercised 28,694 $ 13.08 4,763 $ 8.14 Shares Weighted Average Grant Date Fair Value Shares Weighted Average Grant Date Fair Value RSUs granted 70,729 $ 14.60 78,400 $ 15.48 PSUs granted 16,388 $ 13.94 — $ — Nine Months Ended September 28, 2024 September 30, 2023 Shares Weighted Average Exercise Price Per Share Shares Weighted Average Exercise Price Per Share Options granted 375,312 $ 18.37 262,809 $ 13.28 Options cancelled 282,429 $ 20.61 277,285 $ 21.35 Options exercised 220,602 $ 13.03 24,478 $ 9.50 Shares Weighted Average Grant Date Fair Value Shares Weighted Average Grant Date Fair Value RSUs granted 1,006,817 $ 18.32 1,568,729 $ 13.37 PSUs granted 433,735 $ 22.27 307,273 $ 17.38
Schedule of RSU and PSU Activity Roll forward	The activity under our incentive plans for the periods presented are reflected in the following tables: Three Months Ended September 28, 2024 September 30, 2023 Shares Weighted Average Exercise Price Per Share Shares Weighted Average Exercise Price Per Share Options granted 9,900 $ 12.97 — $ — Options cancelled 207,958 $ 21.66 199,395 $ 21.18 Options exercised 28,694 $ 13.08 4,763 $ 8.14 Shares Weighted Average Grant Date Fair Value Shares Weighted Average Grant Date Fair Value RSUs granted 70,729 $ 14.60 78,400 $ 15.48 PSUs granted 16,388 $ 13.94 — $ — Nine Months Ended September 28, 2024 September 30, 2023 Shares Weighted Average Exercise Price Per Share Shares Weighted Average Exercise Price Per Share Options granted 375,312 $ 18.37 262,809 $ 13.28 Options cancelled 282,429 $ 20.61 277,285 $ 21.35 Options exercised 220,602 $ 13.03 24,478 $ 9.50 Shares Weighted Average Grant Date Fair Value Shares Weighted Average Grant Date Fair Value RSUs granted 1,006,817 $ 18.32 1,568,729 $ 13.37 PSUs granted 433,735 $ 22.27 307,273 $ 17.38

Restructuring and Asset-Relat_2

Restructuring and Asset-Related Charges (Tables)	9 Months Ended
	Sep. 28, 2024
Restructuring and Related Activities [Abstract]
Schedule of Restructuring and Asset Related Costs	The following table summarizes the restructuring and asset-related charges for the periods indicated: (amounts in thousands) North Europe Corporate Total Three Months Ended September 28, 2024 Restructuring severance and employee-related charges $ 5,290 $ 5,880 $ 630 $ 11,800 Other restructuring associated costs 3,025 1,906 — 4,931 Asset-related charges 8,809 — — 8,809 Other restructuring associated costs and asset-related charges 11,834 1,906 — 13,740 Total restructuring and asset-related charges $ 17,124 $ 7,786 $ 630 $ 25,540 Three Months Ended September 30, 2023 Restructuring severance and employee-related charges (income) $ 7,578 $ 801 $ (30) $ 8,349 Other restructuring associated costs 2,790 37 — 2,827 Asset-related charges 1,522 — — 1,522 Other restructuring associated costs and asset-related charges 4,312 37 — 4,349 Total restructuring and asset-related charges (income), net $ 11,890 $ 838 $ (30) $ 12,698 (amounts in thousands) North Europe Corporate Total Nine Months Ended September 28, 2024 Restructuring severance and employee-related charges $ 16,241 $ 13,155 $ 1,190 $ 30,586 Other restructuring associated costs 7,133 4,325 — 11,458 Asset-related charges 16,875 931 196 18,002 Other restructuring associated costs and asset-related charges 24,008 5,256 196 29,460 Total restructuring and asset-related charges $ 40,249 $ 18,411 $ 1,386 $ 60,046 Nine Months Ended September 30, 2023 Restructuring severance and employee-related charges $ 10,920 $ 3,594 $ 796 $ 15,310 Other restructuring associated costs (income) 9,681 (1,154) — 8,527 Asset-related charges 4,759 180 — 4,939 Other restructuring associated costs and asset-related charges (income) 14,440 (974) — 13,466 Total restructuring and asset-related charges $ 25,360 $ 2,620 $ 796 $ 28,776 Costs and cash outlays associated with the plans: North America: Vista, California and Hawkins, Wisconsin Total Estimated Costs Cumulative Costs to-date Costs in the Three Months Ended Costs in the Nine Months Ended (amounts in thousands) September 28, 2024 September 28, 2024 Restructuring severance and employee-related charges (1) $ 11,300 $ 10,714 $ 168 $ 10,714 Other restructuring associated costs (1) 7,400 3,615 2,260 3,615 Product-related cash charges (2) 5,000 4,086 1,436 4,086 Total cash charges 23,700 18,415 3,864 18,415 Asset-related charges (1) 12,100 11,984 8,769 11,984 Inventory and other product-related non-cash charges (3) 4,100 3,706 — 3,706 Total non-cash charges 16,200 15,690 8,769 15,690 Total costs $ 39,900 $ 34,105 $ 12,633 $ 34,105 Total cash outlays $ 29,600 $ 12,265 $ 6,586 $ 12,265 (1) The charges incurred in the three and nine months ended September 28, 2024 were included in restructuring and asset-related charges in the accompanying Consolidated Statement of Operations. (2) The product-related cash charges incurred in the three and nine months ended September 28, 2024 were detrimental to Net Sales in the accompanying Consolidated Statement of Operations. (3) The inventory and other product-related non-cash charges in the three and nine months ended September 28, 2024 were included in Cost of Sales in the accompanying Consolidated Statement of Operations. Costs and cash outlays associated with the plans: Europe Total Estimated Costs Cumulative Costs to-date Costs in the Three Months Ended Costs in the Nine Months Ended (amounts in thousands) September 28, 2024 September 28, 2024 Restructuring severance and employee-related charges (1) $ 20,900 $ 16,094 $ 5,805 $ 13,012 Other restructuring associated costs (1) 5,600 4,625 1,885 4,201 Total cash charges 26,500 20,719 7,690 17,213 Asset-related non-cash charges (1) 600 573 — 573 Total costs $ 27,100 $ 21,292 $ 7,690 $ 17,786 Total cash outlays $ 26,500 $ 15,423 $ 5,629 $ 13,308 (1) The charges incurred in the three and nine months ended September 28, 2024 were included in restructuring and asset-related charges in the accompanying Consolidated Statement of Operations. Costs and cash outlays associated with the plans: North America: Tijuana, Mexico and Vista, California Total Estimated Costs Cumulative Costs to-date Costs in the Three Months Ended Costs in the Nine Months Ended (amounts in thousands) September 28, 2024 September 28, 2024 Restructuring severance and employee-related charges (1) $ 7,800 $ 7,631 $ 129 $ (182) Other restructuring associated costs (1) 2,700 2,614 69 2,013 Total cash charges 10,500 10,245 198 1,831 Asset-related charges (1) 6,600 6,628 — 2,919 Inventory and other product-related non-cash charges (2) 1,500 1,466 — — Total non-cash charges 8,100 8,094 — 2,919 Total costs $ 18,600 $ 18,339 $ 198 $ 4,750 Total cash outlays $ 10,500 $ 9,588 $ 402 $ 2,962 (1) The related charges incurred in the three and nine months ended September 28, 2024 were included in restructuring and asset-related charges in the accompanying Consolidated Statement of Operations. (2) The inventory and other product-related non-cash charges incurred during 2023 were included in Cost of Sales in the Consolidated Statement of Operations. North America: Wedowee, Alabama Total Estimated Costs Cumulative Costs to-date Costs in the Three Months Ended Costs in the Nine Months Ended (amounts in thousands) September 28, 2024 September 28, 2024 Restructuring severance and employee-related charges (1) $ 1,100 $ 1,087 $ 1,087 $ 1,087 Other restructuring associated costs (1) 2,000 239 239 239 Total cash charges 3,100 1,326 1,326 1,326 Asset-related non-cash charges (1) 200 — — — Total costs $ 3,300 $ 1,326 $ 1,326 $ 1,326 Total cash outlays $ 3,100 $ 311 $ 311 $ 311 (1) The related charges incurred in the three and nine months ended September 28, 2024 were included in restructuring and asset-related charges in the accompanying Consolidated Statement of Operations.
Schedule of Restructuring Reserve by Type of Cost	The following is a summary of the restructuring accruals recorded and charges incurred: (amounts in thousands) September 28, 2024 September 30, 2023 Balance as of January 1 $ 3,375 $ 5,021 Current period charges 42,044 23,837 Payments (30,759) (21,831) Currency translation (46) 95 Balance at period end $ 14,614 $ 7,122

Held for Sale (Tables)

Held for Sale (Tables)	9 Months Ended
	Sep. 28, 2024
Discontinued Operations and Disposal Groups [Abstract]
Schedule of Accompanying Balance Sheet	Components of amounts reflected in the consolidated statements of operations related to discontinued operations are presented in the table, as follows: Three Months Ended Nine Months Ended (amounts in thousands) September 30, 2023 September 30, 2023 Net revenues $ — $ 301,876 Cost of sales — 211,575 Gross margin — 90,301 Selling, general and administrative 606 62,083 Operating (loss) income (606) 28,218 Interest income, net — (685) Other income, net (17) (2,274) (Loss) income from discontinued operations before taxes (589) 31,177 Income tax (benefit) expense (1,390) 7,928 Income from discontinued operations, net of tax $ 801 $ 23,249 The cash flows related to discontinued operations have not been segregated and are included in the consolidated statements of cash flows through the divestiture date of July 2, 2023. The following table presents cash flow and non-cash information related to discontinued operations: Nine Months Ended (amounts in thousands) September 30, 2023 Depreciation and amortization $ 5,196 Capital expenditures 6,229 Share-based incentive compensation 812 Provision for bad debt 5,062 As of September 28, 2024 and December 31, 2023, the related assets and liabilities included within the summary below were expected to be disposed of within the next twelve months and are included in assets held for sale and liabilities held for sale in the accompanying consolidated balance sheets. (amounts in thousands) September 28, 2024 December 31, 2023 Assets Inventories $ 16,322 $ 17,337 Other current assets 139 108 Property and equipment, net 63,385 50,672 Intangible assets, net 1,471 1,471 Goodwill 65,000 65,000 Operating lease assets, net 2,416 975 Assets held for sale $ 148,733 $ 135,563 Liabilities Accrued payroll and benefits $ 1,158 $ 901 Accrued expenses and other current liabilities 7,111 6,126 Operating lease liability 1,018 37 Liabilities held for sale $ 9,287 $ 7,064

Other Income, Net (Tables)

Other Income, Net (Tables)	9 Months Ended
	Sep. 28, 2024
Other Income and Expenses [Abstract]
Schedule of Other Income, Net	The table below summarizes the amounts included in other income, net in the accompanying consolidated statements of operations: Three Months Ended Nine Months Ended (amounts in thousands) September 28, 2024 September 30, 2023 September 28, 2024 September 30, 2023 Cash received on investment in real estate $ (3,210) $ — $ (5,737) $ — Pension expense 484 1,618 1,512 4,969 Foreign currency gains, net (311) (216) (1,145) (2,318) Income from refund of deposits for China antidumping and countervailing duties (1) (239) — (3,186) — JW Australia Transition Services Agreement cost recovery (27) (4,000) (6,569) (4,000) Insurance reimbursement — — (1,655) (1,234) Recovery of cost from receipts on impaired notes — (1,325) (1,389) (3,000) Governmental assistance — (1,257) (927) (1,448) Income from short-term investments and forward contracts related to the JW Australia divestiture — (3,109) — (3,109) Other items, net (172) (1,164) (1,130) (841) Total other income, net $ (3,475) $ (9,453) $ (20,226) $ (10,981) (1) Represents the refund of deposits for antidumping and countervailing duties on wood mouldings and millwork products purchased from China from 2020 to 2022.

Derivative Financial Instrume_2

Derivative Financial Instruments (Tables)	9 Months Ended
	Sep. 28, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of Derivative Instruments in Statement of Financial Position, Fair Value	The fair values of derivative instruments held are as follows: Derivative assets (amounts in thousands) Balance Sheet Location September 28, 2024 December 31, 2023 Derivatives not designated as hedging instruments: Foreign currency forward contracts Other current assets $ 685 $ 1,186 Other derivative instruments Other current assets $ 36 $ 38 Derivative liabilities (amounts in thousands) Balance Sheet Location September 28, 2024 December 31, 2023 Derivatives designated as hedging instruments: Interest rate contracts Accrued expenses and other current liabilities $ 342 $ — Interest rate contracts Deferred credits and other liabilities $ 519 $ — Derivatives not designated as hedging instruments: Foreign currency forward contracts Accrued expenses and other current liabilities $ 1,828 $ 2,975 Other derivative instruments Accrued expenses and other current liabilities $ — 21

Fair Value of Financial Instr_2

Fair Value of Financial Instruments (Tables)	9 Months Ended
	Sep. 28, 2024
Fair Value Disclosures [Abstract]
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis	The recorded carrying amounts and fair values of these instruments were as follows: September 28, 2024 (amounts in thousands) Carrying Amount Total Level 1 Level 2 Level 3 Assets: Cash equivalents $ 116,115 $ 116,115 $ 116,115 $ — $ — Derivative assets, recorded in other current assets 721 721 — 721 — Deferred compensation plan assets, recorded in other assets 4,963 4,963 — 4,963 — Liabilities: Debt, recorded in long-term debt and current maturities of long-term debt $ 1,219,800 $ 1,217,502 $ — $ 1,217,502 $ — Derivative liabilities, recorded in accrued expenses and other current liabilities 2,170 2,170 — 2,170 — Derivative liabilities, recorded in deferred credits and other liabilities 519 519 — 519 — December 31, 2023 (amounts in thousands) Carrying Amount Total Level 1 Level 2 Level 3 Assets: Cash equivalents $ 71,139 $ 71,139 $ 71,139 $ — $ — Derivative assets, recorded in other current assets 1,224 1,224 — 1,224 — Deferred compensation plan assets, recorded in other assets 2,098 2,098 — 2,098 — Liabilities: Debt, recorded in long-term debt and current maturities of long-term debt $ 1,232,780 $ 1,209,961 $ — $ 1,209,961 $ — Derivative liabilities, recorded in accrued expenses and other current assets 2,996 2,996 — 2,996 —

Supplemental Cash Flow Inform_2

Supplemental Cash Flow Information (Tables)	9 Months Ended
	Sep. 28, 2024
Supplemental Cash Flow Elements [Abstract]
Schedule of Cash Flow, Supplemental Disclosures	Nine Months Ended (amounts in thousands) September 28, 2024 September 30, 2023 Cash Operating Activities: Operating leases $ 35,397 $ 46,033 Interest payments on financing lease obligations 377 217 Cash paid for amounts included in the measurement of lease liabilities $ 35,774 $ 46,250 Cash Investing Activities: Purchases of securities for deferred compensation plan $ (3,113) $ (1,020) Sale of securities for deferred compensation plan — 127 Change in securities for deferred compensation plan $ (3,113) $ (893) Cash received on notes receivable 31 — Change in notes receivable $ 31 $ — Non-cash Investing Activities: Property, equipment, and intangibles purchased in accounts payable $ 13,378 $ 5,422 Property, equipment, and intangibles purchased with debt 7,272 10,984 Customer accounts receivable converted to notes receivable 393 193 Consideration receivable from sale of business 2,000 — Cash Financing Activities: Borrowings on long-term debt $ 351,225 $ 127,317 Payments of long-term debt (371,536) (672,755) Payments of debt issuance and extinguishment costs, including underwriting fees (5,284) (3,908) Change in long-term debt and payments of debt extinguishment costs $ (25,595) $ (549,346) Cash paid for amounts included in the measurement of finance lease liabilities $ 1,865 $ 1,351 Non-cash Financing Activities: Prepaid insurance funded through short-term debt borrowings $ — $ 16,628 Accounts payable converted to installment notes 5 176 Other Supplemental Cash Flow Information: Cash taxes paid, net of refunds $ 29,575 $ 41,988 Cash interest paid 49,469 53,442

Description of Company and Su_3

Description of Company and Summary of Significant Accounting Policies (Details) $ in Millions	3 Months Ended
	Dec. 31, 2023 USD ($)
Cares Act, Deferral of Social Security Tax
Unusual or Infrequent Item, or Both [Line Items]
Other operating income (expense), net	$ 6.1

Discontinued Operations - Narra

Discontinued Operations - Narrative (Details) - JW Australia $ in Millions, $ in Millions	Sep. 28, 2024 USD ($)	Dec. 31, 2023 USD ($)	Jul. 02, 2023 USD ($)	Apr. 17, 2023 AUD ($)
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Transition services liability	$ 3.9	$ 8.2
Accrued expenses and other current liabilities		$ 6.1
Disposed of by sale
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Adjustment of purchase price			$ 446	$ 688
Cash received from the settlement			$ 3.3

Discontinued Operations- Result

Discontinued Operations- Results of Operations (Details) - Held-for-sale - JW Australia - USD ($) $ in Thousands	3 Months Ended	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2023
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Net revenues	$ 0	$ 301,876
Cost of sales	0	211,575
Gross margin	0	90,301
Selling, general and administrative	606	62,083
Operating (loss) income	(606)	28,218
Interest income, net	0	(685)
Other income, net	(17)	(2,274)
(Loss) income from discontinued operations before taxes	(589)	31,177
Income tax (benefit) expense	(1,390)	7,928
Income from discontinued operations, net of tax	$ 801	$ 23,249

Discontinued Operations- Inform

Discontinued Operations- Information Regarding Cash Flows (Details) - Held-for-sale - JW Australia $ in Thousands	9 Months Ended
	Sep. 30, 2023 USD ($)
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Depreciation and amortization	$ 5,196
Capital expenditures	6,229
Share-based incentive compensation	812
Provision for bad debt	$ 5,062

Accounts Receivable (Details)

Accounts Receivable (Details) - USD ($) $ in Millions	Sep. 28, 2024	Dec. 31, 2023
Receivables [Abstract]
Allowance for doubtful accounts	$ (10.3)	$ (11.3)

Inventories (Details)

Inventories (Details) - USD ($) $ in Thousands	Sep. 28, 2024	Dec. 31, 2023
Inventory Disclosure [Abstract]
Raw materials	$ 392,836	$ 404,360
Work in process	22,928	21,141
Finished goods	88,920	84,954
Inventory valuation reserves	(23,008)	(29,004)
Total inventories	$ 481,676	$ 481,451

Property and Equipment, Net - S

Property and Equipment, Net - Summary (Details) - USD ($) $ in Thousands	Sep. 28, 2024	Dec. 31, 2023
Property, Plant and Equipment [Abstract]
Property and equipment	$ 2,005,861	$ 1,966,371
Accumulated depreciation	(1,335,071)	(1,322,129)
Total property and equipment, net	$ 670,790	$ 644,242

Property and Equipment, Net - N

Property and Equipment, Net - Narrative (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 28, 2024	Sep. 30, 2023	Sep. 28, 2024	Sep. 30, 2023
Property, Plant and Equipment [Line Items]
Impairment of assets				$ 9.1
Gain due to currency translations for foreign assets			$ 1.5
Property, plant and equipment
Property, Plant and Equipment [Line Items]
Impairment of assets	$ 7.9	$ 1.1	$ 13.7	$ 4.3

Property and Equipment, Net - D

Property and Equipment, Net - Depreciation (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 28, 2024	Sep. 30, 2023	Sep. 28, 2024	Sep. 30, 2023
Property, Plant and Equipment [Line Items]
Total depreciation expense	$ 21,820	$ 20,694	$ 64,530	$ 74,110
Cost of sales
Property, Plant and Equipment [Line Items]
Total depreciation expense	20,628	19,315	61,090	69,843
Selling, general and administrative
Property, Plant and Equipment [Line Items]
Total depreciation expense	$ 1,192	$ 1,379	$ 3,440	$ 4,267

Goodwill - Narrative (Details)

Goodwill - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 28, 2024	Sep. 30, 2023	Sep. 28, 2024	Sep. 30, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Fair value in excess of carrying amount (as a percent)	3%		3%
Goodwill impairment (Note 6)	$ 63,445	$ 0	$ 63,445	$ 0

Goodwill - Goodwill by Reportab

Goodwill - Goodwill by Reportable Segment (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 28, 2024	Sep. 30, 2023	Sep. 28, 2024	Sep. 30, 2023	Dec. 31, 2023
Goodwill, Gross [Roll Forward]
Goodwill, gross beginning balance			$ 450,924
Sale of business			(900)
Foreign currency translation			1,422
Goodwill, gross ending balance	$ 451,446		451,446
Goodwill, Impaired, Accumulated Impairment Loss [Roll Forward]
Goodwill, accumulated impairment loss beginning balance			(60,754)
Impairment	(63,445)	$ 0	(63,445)	$ 0
Foreign currency translation			(841)
Goodwill, accumulated impairment loss ending balance	(125,040)		(125,040)
Balance, net of impairment at September 28, 2024	326,406		326,406		$ 390,170
North America
Goodwill, Gross [Roll Forward]
Goodwill, gross beginning balance			182,412
Sale of business			(900)
Foreign currency translation			(114)
Goodwill, gross ending balance	181,398		181,398
Goodwill, Impaired, Accumulated Impairment Loss [Roll Forward]
Goodwill, accumulated impairment loss beginning balance			0
Impairment			0
Foreign currency translation			0
Goodwill, accumulated impairment loss ending balance	0		0
Balance, net of impairment at September 28, 2024	181,398		181,398
Europe
Goodwill, Gross [Roll Forward]
Goodwill, gross beginning balance			268,512
Sale of business			0
Foreign currency translation			1,536
Goodwill, gross ending balance	270,048		270,048
Goodwill, Impaired, Accumulated Impairment Loss [Roll Forward]
Goodwill, accumulated impairment loss beginning balance			(60,754)
Impairment			(63,445)
Foreign currency translation			(841)
Goodwill, accumulated impairment loss ending balance	(125,040)		(125,040)
Balance, net of impairment at September 28, 2024	$ 145,008		$ 145,008

Intangible Assets, Net - Cost a

Intangible Assets, Net - Cost and Accumulated Amortization (Details) - USD ($) $ in Thousands	Sep. 28, 2024	Dec. 31, 2023
Finite-Lived Intangible Assets
Cost	$ 241,038	$ 281,956
Accumulated Amortization	(137,718)	(158,046)
Net Book Value	103,320	123,910
Customer relationships and agreements
Finite-Lived Intangible Assets
Cost	124,094	123,713
Accumulated Amortization	(91,655)	(84,281)
Net Book Value	32,439	39,432
Software
Finite-Lived Intangible Assets
Cost	72,067	113,429
Accumulated Amortization	(28,647)	(58,424)
Net Book Value	43,420	55,005
Trademarks and trade names
Finite-Lived Intangible Assets
Cost	32,204	32,148
Accumulated Amortization	(12,089)	(10,802)
Net Book Value	20,115	21,346
Patents, licenses and rights
Finite-Lived Intangible Assets
Cost	12,673	12,666
Accumulated Amortization	(5,327)	(4,539)
Net Book Value	$ 7,346	$ 8,127

Intangible Assets, Net - Narrat

Intangible Assets, Net - Narrative (Details) - USD ($) $ in Millions	3 Months Ended	9 Months Ended
	Sep. 30, 2023	Sep. 28, 2024	Sep. 30, 2023
Finite-Lived Intangible Assets
Impairment, Intangible Asset, Finite-Lived, Statement of Income or Comprehensive Income [Extensible Enumeration]		Selling, general and administrative
Currency translation increase		$ 0.1
Software
Finite-Lived Intangible Assets
Finite lived intangible assets written off	$ 3.5	$ 14.1	$ 3.5

Intangible Assets, Net - Amorti

Intangible Assets, Net - Amortization Expense (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 28, 2024	Sep. 30, 2023	Sep. 28, 2024	Sep. 30, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Amortization expense	$ 4,713	$ 9,166	$ 28,536	$ 21,166

Accrued Expenses and Other Cu_3

Accrued Expenses and Other Current Liabilities (Details) - USD ($) $ in Thousands	Sep. 28, 2024	Dec. 31, 2023	Sep. 30, 2023
Accounts Payable and Accrued Liabilities, Current
Accrued sales and advertising rebates	$ 75,908	$ 82,732
Current portion of operating lease liability	35,327	32,477
Non-income related taxes	26,348	20,072
Current portion of warranty liability (Note 9)	18,126	22,819	$ 22,034
Accrued freight	16,192	18,963
Current portion of accrued claim costs relating to self-insurance programs	15,509	14,079
Accrued expenses	14,779	15,758
Current portion of restructuring accrual (Note 16)	14,614	3,375
Accrued interest payable	10,989	1,401
Legal claims provision (Note 21)	8,228	2,683
Current portion of UTPs (Note 11)	6,864	0
Deferred revenue and customer deposits	6,764	7,189
Current portion of derivative liability (Note 19)	2,170	2,996
Accrued income taxes payable	1,309	9,252
Total accrued expenses and other current liabilities	$ 253,127	$ 233,796

Warranty Liability - Narrative

Warranty Liability - Narrative (Details) - USD ($) $ in Thousands	9 Months Ended
	Sep. 28, 2024	Dec. 31, 2023	Sep. 30, 2023	Dec. 31, 2022
Product Warranty Liability
Accrued warranty liability	$ 46,765	$ 53,247	$ 52,301	$ 52,389
Product warranty, discount adjustment	2,900
North America
Product Warranty Liability
Accrued warranty liability	$ 40,400
Minimum
Product Warranty Liability
Product warranty term (in years)	1 year
Product warranty discount rate (as a percent)	3.49%
Maximum
Product Warranty Liability
Product warranty term (in years)	10 years
Product warranty discount rate (as a percent)	3.75%

Warranty Liability - Analysis o

Warranty Liability - Analysis of Warranty Liability (Details) - USD ($) $ in Thousands	9 Months Ended
	Sep. 28, 2024	Sep. 30, 2023	Dec. 31, 2023
Movement in Standard and Extended Product Warranty Accrual, Increase (Decrease)
Balance at beginning balance	$ 53,247	$ 52,389
Current period charges	14,741	23,930
Experience adjustments	633	(992)
Payments	(21,792)	(22,925)
Currency translation	(64)	(101)
Balance at ending balance	46,765	52,301
Current portion	(18,126)	(22,034)	$ (22,819)
Long-term portion	$ 28,639	$ 30,267

Long-Term Debt - Long Term Debt

Long-Term Debt - Long Term Debt (Details) $ in Thousands, kr in Millions	Sep. 28, 2024 USD ($)	Sep. 28, 2024 DKK (kr)	Dec. 31, 2023 USD ($)
Debt Instrument
Total Debt	$ 1,219,800		$ 1,232,780
Unamortized debt issuance costs and original issue discounts	(9,063)		(6,528)
Current maturities of long-term debt	(30,854)		(36,177)
Long-term debt	1,179,883		1,190,075
Senior Notes
Debt Instrument
Long-term debt, gross	750,000		600,000
Term Loan Facility | Term Loans
Debt Instrument
Long-term debt, gross	383,569		536,250
Finance leases and other financing arrangements
Debt Instrument
Finance leases and other financing arrangements	64,884		74,460
Mortgage notes
Debt Instrument
Long-term debt, gross	$ 21,347	kr 142.5	$ 22,070
Minimum | Senior Notes
Debt Instrument
Effective interest rate (as a percent)	4.88%	4.88%
Minimum | Finance leases and other financing arrangements
Debt Instrument
Finance lease, rate (as a percent)	1%	1%
Minimum | Mortgage notes
Debt Instrument
Effective interest rate (as a percent)	5.44%	5.44%
Maximum | Senior Notes
Debt Instrument
Effective interest rate (as a percent)	7%	7%
Maximum | Term Loan Facility | Term Loans
Debt Instrument
Effective interest rate (as a percent)	7.36%	7.36%
Maximum | Finance leases and other financing arrangements
Debt Instrument
Finance lease, rate (as a percent)	8.95%	8.95%
Maximum | Mortgage notes
Debt Instrument
Effective interest rate (as a percent)	5.94%	5.94%

Long-Term Debt - Narrative (Det

Long-Term Debt - Narrative (Details) kr in Millions

1 Months Ended

3 Months Ended

9 Months Ended

Sep. 30, 2024 USD ($)

Aug. 31, 2024 USD ($)

Jan. 31, 2024 USD ($) Rate

Jul. 31, 2021 USD ($)

Dec. 31, 2007

Sep. 28, 2024 USD ($)

Sep. 30, 2023 USD ($)

Sep. 28, 2024 USD ($) Rate

Sep. 30, 2023 USD ($)

Sep. 28, 2024 DKK (kr)

Feb. 29, 2024 USD ($)

Dec. 31, 2023 USD ($)

Aug. 03, 2023 USD ($)

Jun. 30, 2023 Rate

May 31, 2020 USD ($)

Dec. 31, 2017 USD ($) tranche

Debt Instrument

Amortization of deferred financing costs

$ 1,870,000

$ 2,148,000

Loss on extinguishment and refinancing of debt (Note 10)

$ 459,000

$ 6,487,000

1,908,000

6,487,000

Long-term debt

0

$ 0

Cash flow hedge | Derivatives designated as hedging instruments:

Debt Instrument

Derivative fixed interest rate (as a percent)

0.317%

Cash flow hedge | Derivatives designated as hedging instruments: | Interest rate swap

Debt Instrument

Derivative fixed interest rate (as a percent)

0.317%

0.395%

Notional amount

$ 370,000,000

Cash flow hedge | Derivatives designated as hedging instruments: | Interest Rate Cap

Debt Instrument

Derivative fixed interest rate (as a percent)

4.50%

Notional amount

$ 100,000,000

$ 370,000,000

Minimum | SOFR | Cash flow hedge | Derivatives designated as hedging instruments: | Interest Rate Cap

Debt Instrument

Derivative variable interest rate (as a percent)

3.982%

Minimum | LIBOR | Cash flow hedge | Derivatives designated as hedging instruments: | Interest rate swap

Debt Instrument

Derivative variable interest rate (as a percent)

0.10%

0%

Maximum | SOFR | Cash flow hedge | Derivatives designated as hedging instruments: | Interest rate swap

Debt Instrument

Derivative variable interest rate (as a percent)

0.10%

Maximum | SOFR | Cash flow hedge | Derivatives designated as hedging instruments: | Interest Rate Cap

Debt Instrument

Derivative variable interest rate (as a percent)

3.895%

U.S. Facility | Mortgage notes

Debt Instrument

Debt instrument face amount

$ 550,000,000

U.S. Facility | Mortgage notes | Corporate credit rating

Debt Instrument

Derivative variable interest rate (as a percent)

0%

U.S. Facility | Minimum | Mortgage notes | Corporate credit rating

Debt Instrument

Debt instrument, variable rate (as a percent)

2%

U.S. Facility | Maximum | Mortgage notes | Corporate credit rating

Debt Instrument

Debt instrument, variable rate (as a percent)

2.25%

Term Loans

Debt Instrument

Unamortized debt issuance costs

$ 800,000

Term Loans | Minimum | SOFR

Debt Instrument

Debt instrument, variable rate (as a percent) | Rate

1.75%

Term Loans | Maximum | SOFR

Debt Instrument

Debt instrument, variable rate (as a percent) | Rate

2%

Interest rate swap | Cash flow hedge | Derivatives designated as hedging instruments:

Debt Instrument

Derivative fixed interest rate (as a percent)

0.395%

ABL Facility | Revolving credit facility

Debt Instrument

Derivative variable interest rate (as a percent)

0%

Line fee (as a percent) | Rate

0.25%

Maximum borrowing capacity

$ 500,000,000

ABL Facility | Revolving credit facility | US borrowers

Debt Instrument

Maximum borrowing capacity

465,000,000

ABL Facility | Revolving credit facility | Canadian borrowers

Debt Instrument

Maximum borrowing capacity

$ 35,000,000

ABL Facility | Minimum | Revolving credit facility | LIBOR

Debt Instrument

Debt instrument, variable rate (as a percent)

1.25%

ABL Facility | Minimum | Revolving credit facility | Base rate

Debt Instrument

Debt instrument, variable rate (as a percent)

0.25%

ABL Facility | Maximum | Revolving credit facility | LIBOR

Debt Instrument

Debt instrument, variable rate (as a percent)

1.50%

ABL Facility | Maximum | Revolving credit facility | Base rate

Debt Instrument

Debt instrument, variable rate (as a percent)

0.50%

Senior Notes

Debt Instrument

Debt instrument face amount

$ 800,000,000

Number of tranches (in tranches) | tranche

2

Pre-tax loss redemption amount

6,500,000

In call premium

$ 3,900,000

Amortization of deferred financing costs

2,600,000

Long-term debt, gross

750,000,000

750,000,000

$ 600,000,000

Senior Notes | Subsequent event

Debt Instrument

Pre-tax loss redemption amount

$ 500,000

Long-term debt

$ 200,000,000

Senior Notes | Minimum

Debt Instrument

Debt instrument face amount

200,000,000

250,000,000

200,000,000

250,000,000

$ 250,000,000

Senior Notes | Maximum

Debt Instrument

Debt instrument face amount

200,000,000

$ 200,000,000

200,000,000

$ 200,000,000

$ 200,000,000

Senior Notes | Senior Note Maturing December 2025

Debt Instrument

Debt instrument face amount

$ 400,000,000

Senior Notes | Senior Secured Notes Maturing May 2025

Debt Instrument

Debt instrument stated interest rate (as a percent)

6.25%

6.25%

4.63%

Senior secured notes

$ 250,000,000

Debt instrument discount rate (as a percent)

1.25%

Senior Notes | Senior Note Maturing December 2027

Debt Instrument

Debt instrument face amount

$ 400,000,000

Debt instrument stated interest rate (as a percent)

4.88%

Senior Notes | Senior Note Maturing September 2032

Debt Instrument

Debt instrument face amount

$ 350,000,000

Debt instrument stated interest rate (as a percent)

7%

Debt instrument discount rate (as a percent)

1.25%

Debt issuance costs

$ 5,500,000

Repayments of debt

$ 150,000,000

Senior Notes | Senior Note Maturing September 2032 | Subsequent event

Debt Instrument

Debt instrument stated interest rate (as a percent)

4.63%

Term Loan Facility | Term Loans

Debt Instrument

Premium payable (as a percent)

1%

Repayment (as a percent)

0.25%

Loss on extinguishment and refinancing of debt (Note 10)

$ 1,400,000

Long-term debt

383,100,000

383,100,000

Long-term debt, gross

383,569,000

383,569,000

536,250,000

Letter of credit | Revolving credit facility

Debt Instrument

Letters of credit

(2,800,000)

(2,800,000)

Revolving credit facility | ABL Facility | Revolving credit facility

Debt Instrument

Borrowing availability

428,200,000

428,200,000

Finance leases and other financing arrangements

Debt Instrument

Finance leases and other financing arrangements

64,884,000

64,884,000

74,460,000

Mortgage notes

Debt Instrument

Debt instrument term (in years)

30 years

Long-term debt, gross

$ 21,347,000

$ 21,347,000

kr 142.5

$ 22,070,000

Income Taxes (Details)

Income Taxes (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 28, 2024	Sep. 30, 2023	Sep. 28, 2024	Sep. 30, 2023	Dec. 31, 2023
Income Tax Disclosure [Abstract]
Effective tax rate (as a percent)	(11.00%)	50.70%	(12.60%)	39.80%
Income tax expense (benefit)	$ 7,251	$ 17,399	$ 13,383	$ 31,638
Discrete adjustment expense (benefit)	4,800	7,000	16,800	9,600
Increase in uncertain tax positions	2,400	2,300	12,100	2,000
Adjustments and settlements, expense (benefit)	2,600		4,300
Change in enacted tax rate, expense (benefit)		900		600
Foreign tax rate differential		$ 5,700		5,700
Increase for tax positions taken during the prior period				$ 1,600
Unrecognized tax benefits	49,500		49,500		$ 38,900
Current portion of UTPs (Note 11)	$ 6,864		$ 6,864		$ 0

Segment Information - Narrative

Segment Information - Narrative (Details)	9 Months Ended
	Sep. 28, 2024 segment
Segment Reporting [Abstract]
Number of reportable segments	2

Segment Information - Reportabl

Segment Information - Reportable Segment (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 28, 2024	Sep. 30, 2023	Sep. 28, 2024	Sep. 30, 2023
Segment Reporting Information [Line Items]
Net revenues	$ 934,716	$ 1,076,980	$ 2,879,858	$ 3,283,269
Income (loss) from continuing operations, net of tax	(72,962)	16,908	(119,183)	47,875
Income tax expense (benefit)	7,251	17,399	13,383	31,638
Depreciation and amortization	27,874	30,951	97,552	97,508
Interest expense (income), net	16,319	16,737	48,575	59,083
Net legal and professional expenses and settlements	12,276	7,401	49,812	13,609
Goodwill impairment	63,445	0	63,445	0
Restructuring and asset-related charges	25,540	12,698	60,046	28,776
M&A related costs	3,045	1,202	9,223	5,171
Net (gain) loss on sale of business, property, and equipment	(5,421)	(4,040)	(8,176)	(3,953)
Loss on extinguishment and refinancing of debt (Note 10)	459	6,487	1,908	6,487
Share-based compensation expense	2,459	3,382	12,592	12,255
Non-cash foreign exchange transaction/translation loss (gain)	(363)	271	(3,101)	(897)
Other special items	1,721	(3,655)	9,114	(3,623)
Adjusted EBITDA from continuing operations	81,643	105,741	235,190	293,929
Impairment of assets				9,100
Software
Segment Reporting Information [Line Items]
Finite lived intangible assets written off		3,500	14,100	3,500
Accelerated depreciation				9,100
North America
Segment Reporting Information [Line Items]
Net revenues	677,945	790,285	2,068,538	2,375,430
Goodwill impairment			0
Europe
Segment Reporting Information [Line Items]
Net revenues	256,771	286,695	811,320	907,839
Goodwill impairment			63,445
Operating segments
Segment Reporting Information [Line Items]
Net revenues	937,376	1,080,019	2,884,908	3,287,508
Operating segments | North America
Segment Reporting Information [Line Items]
Net revenues	677,992	790,327	2,068,645	2,375,633
Income (loss) from continuing operations, net of tax	35,781	40,469	82,783	126,987
Income tax expense (benefit)	6,455	27,412	26,800	63,072
Depreciation and amortization	18,142	17,128	55,033	62,625
Interest expense (income), net	819	604	2,137	4,188
Net legal and professional expenses and settlements	619	802	2,336	804
Goodwill impairment	0		0
Restructuring and asset-related charges	17,124	11,890	40,249	25,360
M&A related costs	0	84	0	651
Net (gain) loss on sale of business, property, and equipment	(5,288)	748	(7,839)	1,132
Loss on extinguishment and refinancing of debt (Note 10)	0	0	0	0
Share-based compensation expense	349	914	2,610	3,366
Non-cash foreign exchange transaction/translation loss (gain)	53	131	315	(168)
Other special items	734	(220)	7,199	(39)
Adjusted EBITDA from continuing operations	74,788	99,962	211,623	287,978
Operating segments | Europe
Segment Reporting Information [Line Items]
Net revenues	259,384	289,692	816,263	911,875
Income (loss) from continuing operations, net of tax	(66,662)	10,672	(71,665)	28,627
Income tax expense (benefit)	2,626	5,974	15,784	10,469
Depreciation and amortization	7,884	7,482	22,940	22,414
Interest expense (income), net	(14)	147	917	692
Net legal and professional expenses and settlements	995	1,264	2,367	3,720
Goodwill impairment	63,445		63,445
Restructuring and asset-related charges	7,786	838	18,411	2,620
M&A related costs	0	0	0	0
Net (gain) loss on sale of business, property, and equipment	33	(4,791)	(153)	(5,088)
Loss on extinguishment and refinancing of debt (Note 10)	0	0	0	0
Share-based compensation expense	346	455	994	1,438
Non-cash foreign exchange transaction/translation loss (gain)	(475)	2,343	(3,771)	1,192
Other special items	291	67	1,911	(134)
Adjusted EBITDA from continuing operations	16,255	24,451	51,180	65,950
Intersegment net revenues
Segment Reporting Information [Line Items]
Net revenues	(2,660)	(3,039)	(5,050)	(4,239)
Intersegment net revenues | North America
Segment Reporting Information [Line Items]
Net revenues	(47)	(42)	(107)	(203)
Intersegment net revenues | Europe
Segment Reporting Information [Line Items]
Net revenues	(2,613)	(2,997)	(4,943)	(4,036)
Corporate and Unallocated Costs
Segment Reporting Information [Line Items]
Net revenues	0	0	0	0
Income (loss) from continuing operations, net of tax	(42,081)	(34,233)	(130,301)	(107,739)
Income tax expense (benefit)	(1,830)	(15,987)	(29,201)	(41,903)
Depreciation and amortization	1,848	6,341	19,579	12,469
Interest expense (income), net	15,514	15,986	45,521	54,203
Net legal and professional expenses and settlements	10,662	5,335	45,109	9,085
Goodwill impairment	0		0
Restructuring and asset-related charges	630	(30)	1,386	796
M&A related costs	3,045	1,118	9,223	4,520
Net (gain) loss on sale of business, property, and equipment	(166)	3	(184)	3
Loss on extinguishment and refinancing of debt (Note 10)	459	6,487	1,908	6,487
Share-based compensation expense	1,764	2,013	8,988	7,451
Non-cash foreign exchange transaction/translation loss (gain)	59	(2,203)	355	(1,921)
Other special items	696	(3,502)	4	(3,450)
Adjusted EBITDA from continuing operations	$ (9,400)	$ (18,672)	$ (27,613)	$ (59,999)

Segment Information - Reconcili

Segment Information - Reconciliation of Net Income (Loss) to EBITDA (Details) - USD ($)	1 Months Ended	3 Months Ended		9 Months Ended
	Jan. 31, 2024	Sep. 28, 2024	Sep. 30, 2023	Sep. 28, 2024	Sep. 30, 2023	Aug. 03, 2023	May 31, 2020	Dec. 31, 2017
Segment Reporting Information [Line Items]
(Loss) income from continuing operations, net of tax		$ (72,962,000)	$ 16,908,000	$ (119,183,000)	$ 47,875,000
Income tax expense (benefit)		7,251,000	17,399,000	13,383,000	31,638,000
Depreciation and amortization		27,874,000	30,951,000	97,552,000	97,508,000
Interest expense, net		16,319,000	16,737,000	48,575,000	59,083,000
Net legal and professional expenses and settlements		12,276,000	7,401,000	49,812,000	13,609,000
Goodwill impairment		63,445,000	0	63,445,000	0
Restructuring and asset-related charges (Note 16)		25,540,000	12,698,000	60,046,000	28,776,000
M&A related costs		3,045,000	1,202,000	9,223,000	5,171,000
Net (gain) on sale of business and property and equipment		(5,421,000)	(4,040,000)	(8,176,000)	(3,953,000)
Loss on extinguishment and refinancing of debt (Note 10)		459,000	6,487,000	1,908,000	6,487,000
Share-based compensation expense		2,459,000	3,382,000	12,592,000	12,255,000
Non-cash foreign exchange transaction/translation (gain) loss		(363,000)	271,000	(3,101,000)	(897,000)
Other special items		1,721,000	(3,655,000)	9,114,000	(3,623,000)
Adjusted EBITDA from continuing operations		81,643,000	105,741,000	235,190,000	293,929,000
Non-recurring transformation journey expenses		12,000,000	7,100,000	46,600,000	12,000,000
Transformation consultant		7,000,000	5,800,000	35,400,000	6,200,000
Litigation settlement, expense		200,000	200,000	2,800,000	1,600,000
Product and inventory charges related to EBITDA		1,400,000		7,800,000
Gain (loss) on foreign equity compensation				(4,300,000)
Foreign equity compensation			(3,100,000)		(3,100,000)
Cash received on impaired note					1,500,000
Software
Segment Reporting Information [Line Items]
Finite lived intangible assets written off			3,500,000	14,100,000	3,500,000
North America
Segment Reporting Information [Line Items]
Goodwill impairment				0
Gain (loss) on foreign equity compensation				(1,600,000)
Term Loan Facility | Term Loans
Segment Reporting Information [Line Items]
Loss on extinguishment and refinancing of debt (Note 10)	$ 1,400,000
Gain (loss) on extinguishment of debt, amendment		500,000		1,900,000
Senior Notes
Segment Reporting Information [Line Items]
Debt instrument face amount								$ 800,000,000
Senior Notes | Senior Secured Notes Maturing May 2025
Segment Reporting Information [Line Items]
Debt instrument stated interest rate (as a percent)						6.25%	6.25%	4.63%
Senior Notes | Minimum
Segment Reporting Information [Line Items]
Debt instrument face amount		200,000,000	250,000,000	200,000,000	250,000,000	$ 250,000,000
Senior Notes | Maximum
Segment Reporting Information [Line Items]
Debt instrument face amount		$ 200,000,000	$ 200,000,000	$ 200,000,000	$ 200,000,000	$ 200,000,000

Capital Stock (Details)

Capital Stock (Details) - USD ($) $ / shares in Units, $ in Millions	3 Months Ended	9 Months Ended
	Sep. 28, 2024	Sep. 28, 2024	Dec. 31, 2023	Jul. 28, 2022	Jul. 27, 2022
Equity [Abstract]
Shares held in employee trust (in shares)	193,941	193,941	193,941
Shares held in employee trust	$ 12.4	$ 12.4	$ 12.4
Share authorized for repurchase	$ 175.7	$ 175.7		$ 200	$ 400
Common shares repurchased (in shares)	1,600,000	1,600,000
Repurchased common stock average price (in dollars per share)	$ 15.18	$ 15.18

Earnings Per Share - Basic and

Earnings Per Share - Basic and Diluted Income Per Share Calculations (Details) - shares	3 Months Ended		9 Months Ended
	Sep. 28, 2024	Sep. 30, 2023	Sep. 28, 2024	Sep. 30, 2023
Earnings Per Share [Abstract]
Weighted average outstanding shares of Common Stock basic (in shares)	84,554,174	85,182,678	85,115,070	84,915,519
Restricted stock units and options to purchase Common Stock (in shares)	0	1,167,162	0	813,617
Weighted average outstanding shares of Common Stock diluted (in shares)	84,554,174	86,349,840	85,115,070	85,729,136

Earnings Per Share - Potentiall

Earnings Per Share - Potentially Dilutive Securities (Details) - shares	3 Months Ended		9 Months Ended
	Sep. 28, 2024	Sep. 30, 2023	Sep. 28, 2024	Sep. 30, 2023
Common Stock options
Incremental Weighted Average Shares Attributable to Dilutive Effect
Antidilutive securities excluded from computation of diluted earnings per share (in shares)	1,209,341	1,384,007	1,243,831	1,678,769
Restricted stock units
Incremental Weighted Average Shares Attributable to Dilutive Effect
Antidilutive securities excluded from computation of diluted earnings per share (in shares)	951,656	18,161	1,087,802	41,552
Performance share units
Incremental Weighted Average Shares Attributable to Dilutive Effect
Antidilutive securities excluded from computation of diluted earnings per share (in shares)	296,521	25,774	276,400	229,841

Stock Compensation - Activity (

Stock Compensation - Activity (Details) - $ / shares	3 Months Ended		9 Months Ended
	Sep. 28, 2024	Sep. 30, 2023	Sep. 28, 2024	Sep. 30, 2023
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]
Options granted (in shares)	9,900	0	375,312	262,809
Options canceled (in shares)	207,958	199,395	282,429	277,285
Options exercised (in shares)	28,694	4,763	220,602	24,478
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]
Options granted (usd per share)	$ 12.97	$ 0	$ 18.37	$ 13.28
Options canceled (usd per share)	21.66	21.18	20.61	21.35
Options exercised (usd per share)	$ 13.08	$ 8.14	$ 13.03	$ 9.50
RSUs
Weighted Average Grant-Date Fair Value Per Share
Equity instruments granted (in shares)	70,729	78,400	1,006,817	1,568,729
Equity instruments granted, weighted average exercise price (usd per share)	$ 14.60	$ 15.48	$ 18.32	$ 13.37
PSU's
Weighted Average Grant-Date Fair Value Per Share
Equity instruments granted (in shares)	16,388	0	433,735	307,273
Equity instruments granted, weighted average exercise price (usd per share)	$ 13.94	$ 0	$ 22.27	$ 17.38

Stock Compensation - Narrative

Stock Compensation - Narrative (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 28, 2024	Sep. 30, 2023	Sep. 28, 2024	Sep. 30, 2023
Share-based Compensation Arrangement by Share-based Payment Award
Stock-based compensation	$ 2.5	$ 3.4	$ 12.6	$ 12.3
Performance share units
Share-based Compensation Arrangement by Share-based Payment Award
Stock compensation not yet recognized	$ 17.5		$ 17.5
Recognition period for stock compensation not yet recognized (in years)			1 year 5 months 23 days

Restructuring and Asset-Relat_3

Restructuring and Asset-Related Charges - Impairment by Segment (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 28, 2024	Sep. 30, 2023	Sep. 28, 2024	Sep. 30, 2023
Restructuring Cost and Reserve
Restructuring severance and employee-related charges (income)	$ 11,800	$ 8,349	$ 30,586	$ 15,310
Other restructuring associated costs	4,931	2,827	11,458	8,527
Asset-related charges	8,809	1,522	18,002	4,939
Other restructuring associated costs and asset-related charges	13,740	4,349	29,460	13,466
Total restructuring and asset-related charges, net	25,540	12,698	60,046	28,776
Operating segments | North America
Restructuring Cost and Reserve
Restructuring severance and employee-related charges (income)	5,290	7,578	16,241	10,920
Other restructuring associated costs	3,025	2,790	7,133	9,681
Asset-related charges	8,809	1,522	16,875	4,759
Other restructuring associated costs and asset-related charges	11,834	4,312	24,008	14,440
Total restructuring and asset-related charges, net	17,124	11,890	40,249	25,360
Operating segments | Europe
Restructuring Cost and Reserve
Restructuring severance and employee-related charges (income)	5,880	801	13,155	3,594
Other restructuring associated costs	1,906	37	4,325	(1,154)
Asset-related charges	0	0	931	180
Other restructuring associated costs and asset-related charges	1,906	37	5,256	(974)
Total restructuring and asset-related charges, net	7,786	838	18,411	2,620
Corporate and Unallocated Costs
Restructuring Cost and Reserve
Restructuring severance and employee-related charges (income)	630	(30)	1,190	796
Other restructuring associated costs	0	0	0	0
Asset-related charges	0	0	196	0
Other restructuring associated costs and asset-related charges	0	0	196	0
Total restructuring and asset-related charges, net	$ 630	$ (30)	$ 1,386	$ 796

Restructuring and Asset-Relat_4

Restructuring and Asset-Related Charges - Restructuring Accrual (Details) - USD ($) $ in Thousands	9 Months Ended
	Sep. 28, 2024	Sep. 30, 2023
Restructuring Reserve
Restructuring reserve, beginning balance	$ 3,375	$ 5,021
Current period charges	42,044	23,837
Payments	(30,759)	(21,831)
Currency translation	(46)	95
Restructuring reserve, ending balance	$ 14,614	$ 7,122

Restructuring and Asset-Relat_5

Restructuring and Asset-Related Charges - Narrative (Details) $ in Thousands			3 Months Ended		9 Months Ended		12 Months Ended
	Apr. 11, 2024 manufacturingFacility	Jan. 26, 2023 USD ($)	Sep. 28, 2024 USD ($) manufacturingFacility	Sep. 30, 2023 USD ($) manufacturingFacility	Sep. 28, 2024 USD ($)	Sep. 30, 2023 USD ($)	Dec. 31, 2023 USD ($) manufacturingFacility	Dec. 31, 2022 USD ($)
Restructuring Cost and Reserve
Restructuring reserve			$ 14,614	$ 7,122	$ 14,614	$ 7,122	$ 3,375	$ 5,021
Current portion of restructuring accrual (Note 16)			14,614		14,614		$ 3,375
Other restructuring associated costs			4,931	$ 2,827	11,458	8,527
Total cash outlays					30,759	$ 21,831
European Operation Transformation
Restructuring Cost and Reserve
Restructuring reserve			5,400		5,400
Current portion of restructuring accrual (Note 16)			11,000		11,000
Total costs			7,690		17,786
Total cash outlays			5,629		13,308
Footprint Rationalization Efforts
Restructuring Cost and Reserve
Total costs			198		4,750
Total cash outlays			402		2,962
Footprint Rationalization Efforts | Mexico
Restructuring Cost and Reserve
Number of manufacturing facilities to close | manufacturingFacility				2
Restructuring reserve			900		900
Current portion of restructuring accrual (Note 16)			600		600
Footprint And Drive Operations
Restructuring Cost and Reserve
Total costs			1,326		1,326
Total cash outlays			311		311
Footprint And Drive Operations | ALABAMA
Restructuring Cost and Reserve
Restructuring reserve			2,800		2,800
Current portion of restructuring accrual (Note 16)			1,000		1,000
Manufacturing Facility Closure Plan
Restructuring Cost and Reserve
Total costs			12,633		34,105
Total cash outlays			6,586		12,265
Europe | European Operation Transformation
Restructuring Cost and Reserve
Number of manufacturing facilities to close | manufacturingFacility							2
Facility Closing
Restructuring Cost and Reserve
Restructuring reserve			5,500		5,500
Current portion of restructuring accrual (Note 16)			$ 17,300		17,300
Facility Closing | Footprint Rationalization Efforts | Europe
Restructuring Cost and Reserve
Number of manufacturing facilities to close | manufacturingFacility			2
Total costs					13,700
Restructuring severance and employee related charges			$ 6,700
Restructuring cost incurred, cash outlay			1,800
Other restructuring associated costs			$ 5,200
Facility Closing | Manufacturing Facility Closure Plan
Restructuring Cost and Reserve
Total costs							$ 17,700
Total cash outlays		$ 12,900
Facility Closing | North America
Restructuring Cost and Reserve
Number of manufacturing facilities to close | manufacturingFacility	2
Severance And Termination Charges | Europe | European Operation Transformation
Restructuring Cost and Reserve
Total costs					6,300
Severance And Termination Charges | Europe | European Operation Transformation | Maximum
Restructuring Cost and Reserve
Total costs					$ 27,100
Capital Expenditures | Manufacturing Facility Closure Plan
Restructuring Cost and Reserve
Total costs		$ 1,100

Restructuring and Asset-Relat_6

Restructuring and Asset-Related Charges - Summary of Costs and Cash Outlays (Details) - USD ($) $ in Thousands		3 Months Ended	9 Months Ended
	Jan. 26, 2023	Sep. 28, 2024	Sep. 28, 2024	Sep. 30, 2023
Restructuring Cost and Reserve
Total cash outlays			$ 30,759	$ 21,831
Manufacturing Facility Closure Plan
Restructuring Cost and Reserve
Restructuring expected cost		$ 39,900	39,900
Cost incurred to date		34,105	34,105
Total costs		12,633	34,105
Total cash outlays			29,600
Cumulative costs		12,265	12,265
Total cash outlays		6,586	12,265
Manufacturing Facility Closure Plan | Restructuring severance and employee-related charges
Restructuring Cost and Reserve
Restructuring expected cost		11,300	11,300
Cost incurred to date		10,714	10,714
Total costs		168	10,714
Manufacturing Facility Closure Plan | Other restructuring associated costs
Restructuring Cost and Reserve
Restructuring expected cost		7,400	7,400
Cost incurred to date		3,615	3,615
Total costs		2,260	3,615
Manufacturing Facility Closure Plan | Product-related cash charges
Restructuring Cost and Reserve
Restructuring expected cost		5,000	5,000
Cost incurred to date		4,086	4,086
Total costs		1,436	4,086
Manufacturing Facility Closure Plan | Total cash charges
Restructuring Cost and Reserve
Restructuring expected cost		23,700	23,700
Cost incurred to date		18,415	18,415
Total costs		3,864	18,415
Manufacturing Facility Closure Plan | Asset-related charges
Restructuring Cost and Reserve
Restructuring expected cost		12,100	12,100
Cost incurred to date		11,984	11,984
Total costs		8,769	11,984
Manufacturing Facility Closure Plan | Inventory and other product-related non-cash charges
Restructuring Cost and Reserve
Restructuring expected cost		4,100	4,100
Cost incurred to date		3,706	3,706
Total costs		0	3,706
Manufacturing Facility Closure Plan | Total non-cash charges
Restructuring Cost and Reserve
Restructuring expected cost		16,200	16,200
Cost incurred to date		15,690	15,690
Total costs		8,769	15,690
Manufacturing Facility Closure Plan | Capital Expenditures
Restructuring Cost and Reserve
Total costs	$ 1,100
European Operation Transformation
Restructuring Cost and Reserve
Restructuring expected cost		27,100	27,100
Cost incurred to date		21,292	21,292
Total costs		7,690	17,786
Total cash outlays			26,500
Cumulative costs		15,423	15,423
Total cash outlays		5,629	13,308
European Operation Transformation | Restructuring severance and employee-related charges
Restructuring Cost and Reserve
Restructuring expected cost		20,900	20,900
Cost incurred to date		16,094	16,094
Total costs		5,805	13,012
European Operation Transformation | Other restructuring associated costs
Restructuring Cost and Reserve
Restructuring expected cost		5,600	5,600
Cost incurred to date		4,625	4,625
Total costs		1,885	4,201
European Operation Transformation | Total cash charges
Restructuring Cost and Reserve
Restructuring expected cost		26,500	26,500
Cost incurred to date		20,719	20,719
Total costs		7,690	17,213
European Operation Transformation | Asset-related non-cash charges
Restructuring Cost and Reserve
Restructuring expected cost		600	600
Cost incurred to date		573	573
Total costs		0	573
Footprint Rationalization Efforts
Restructuring Cost and Reserve
Restructuring expected cost		18,600	18,600
Cost incurred to date		18,339	18,339
Total costs		198	4,750
Total cash outlays			10,500
Cumulative costs		9,588	9,588
Total cash outlays		402	2,962
Footprint Rationalization Efforts | Restructuring severance and employee-related charges
Restructuring Cost and Reserve
Restructuring expected cost		7,800	7,800
Cost incurred to date		7,631	7,631
Total costs		129	(182)
Footprint Rationalization Efforts | Other restructuring associated costs
Restructuring Cost and Reserve
Restructuring expected cost		2,700	2,700
Cost incurred to date		2,614	2,614
Total costs		69	2,013
Footprint Rationalization Efforts | Total cash charges
Restructuring Cost and Reserve
Restructuring expected cost		10,500	10,500
Cost incurred to date		10,245	10,245
Total costs		198	1,831
Footprint Rationalization Efforts | Asset-related charges
Restructuring Cost and Reserve
Restructuring expected cost		6,600	6,600
Cost incurred to date		6,628	6,628
Total costs		0	2,919
Footprint Rationalization Efforts | Inventory and other product-related non-cash charges
Restructuring Cost and Reserve
Restructuring expected cost		1,500	1,500
Cost incurred to date		1,466	1,466
Total costs		0	0
Footprint Rationalization Efforts | Total non-cash charges
Restructuring Cost and Reserve
Restructuring expected cost		8,100	8,100
Cost incurred to date		8,094	8,094
Total costs		0	2,919
Footprint And Drive Operations
Restructuring Cost and Reserve
Restructuring expected cost		3,300	3,300
Cost incurred to date		1,326	1,326
Total costs		1,326	1,326
Total cash outlays			3,100
Cumulative costs		311	311
Total cash outlays		311	311
Footprint And Drive Operations | Restructuring severance and employee-related charges
Restructuring Cost and Reserve
Restructuring expected cost		1,100	1,100
Cost incurred to date		1,087	1,087
Total costs		1,087	1,087
Footprint And Drive Operations | Other restructuring associated costs
Restructuring Cost and Reserve
Restructuring expected cost		2,000	2,000
Cost incurred to date		239	239
Total costs		239	239
Footprint And Drive Operations | Total cash charges
Restructuring Cost and Reserve
Restructuring expected cost		3,100	3,100
Cost incurred to date		1,326	1,326
Total costs		1,326	1,326
Footprint And Drive Operations | Asset-related charges
Restructuring Cost and Reserve
Restructuring expected cost		200	200
Cost incurred to date		0	0
Total costs		$ 0	$ 0

Held for Sale (Details)

Held for Sale (Details) - USD ($) $ in Thousands	Sep. 28, 2024	Dec. 31, 2023
Assets
Assets held for sale	$ 2,200
Disposal Group, Held-for-sale, Not Discontinued Operations
Assets
Inventories	16,322
Other current assets	139
Property and equipment, net	63,385
Intangible assets, net	1,471
Goodwill	65,000
Operating lease assets, net	2,416
Assets held for sale	148,733
Liabilities
Accrued payroll and benefits	1,158
Accrued expenses and other current liabilities	7,111
Operating lease liability	1,018
Liabilities held for sale	$ 9,287
Disposal Group, Held-for-sale, Not Discontinued Operations | Towanda
Assets
Inventories		$ 17,337
Other current assets		108
Property and equipment, net		50,672
Intangible assets, net		1,471
Goodwill		65,000
Operating lease assets, net		975
Assets held for sale		135,563
Liabilities
Accrued payroll and benefits		901
Accrued expenses and other current liabilities		6,126
Operating lease liability		37
Liabilities held for sale		$ 7,064

Other Income, Net - Schedule of

Other Income, Net - Schedule of Other Income, Net (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 28, 2024	Sep. 30, 2023	Sep. 28, 2024	Sep. 30, 2023
Other Income and Expenses [Abstract]
Cash received on investment in real estate	$ (3,210)	$ 0	$ (5,737)	$ 0
Pension expense	484	1,618	1,512	4,969
Foreign currency gains, net	(311)	(216)	(1,145)	(2,318)
Income from refund of deposits for China antidumping and countervailing duties	(239)	0	(3,186)	0
JW Australia Transition Services Agreement cost recovery	(27)	(4,000)	(6,569)	(4,000)
Insurance reimbursement	0	0	(1,655)	(1,234)
Recovery of cost from receipts on impaired notes	0	(1,325)	(1,389)	(3,000)
Governmental assistance	0	(1,257)	(927)	(1,448)
Income from short-term investments and forward contracts related to the JW Australia divestiture	0	(3,109)	0	(3,109)
Other items, net	(172)	(1,164)	(1,130)	(841)
Total other income, net	$ (3,475)	$ (9,453)	$ (20,226)	$ (10,981)

Derivative Financial Instrume_3

Derivative Financial Instruments - Narrative (Details) $ in Millions, $ in Millions	3 Months Ended		9 Months Ended
	Sep. 28, 2024 USD ($)	Sep. 30, 2023 USD ($)	Sep. 28, 2024 USD ($)	Sep. 30, 2023 USD ($)	Feb. 29, 2024 USD ($)	Jun. 30, 2023 Rate	Apr. 18, 2023 AUD ($) Rate	May 31, 2020 USD ($)
Notional Disclosures
Realized gain (loss) on hedges	$ (1.1)	$ 0.1	$ (0.4)	$ 1.1
Forward contracts to sell a total							$ 420
Derivative, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]	Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax	Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax
Loss expected to be reclassified to interest income over the next twelve months	$ 0.4		0.4
Minimum
Notional Disclosures
Exchange rate (USD per AUD) | Rate							67.51%
Maximum
Notional Disclosures
Exchange rate (USD per AUD) | Rate							67.59%
Designated as hedging instrument | Cash flow hedge
Notional Disclosures
Derivative fixed interest rate (as a percent)						0.317%
Foreign Exchange Contracts, Forecasted Transactions | Not Designated as Hedging Instrument
Notional Disclosures
Notional amount	81		81
Foreign Exchange Contracts, Foreign Currency Loans and Interest | Not Designated as Hedging Instrument
Notional Disclosures
Notional amount	121.6		121.6
Foreign Currency Forward Contracts | Not Designated as Hedging Instrument
Notional Disclosures
Realized gain (loss) on hedges	(0.9)	$ 0.4	0.6	0.5
Interest rate swap | Designated as hedging instrument | Cash flow hedge
Notional Disclosures
Notional amount								$ 370
Derivative fixed interest rate (as a percent)						0.317%		0.395%
Gains reclassified	$ 0.2	$ 4.6	$ 0.5	$ 12.7
Interest rate swap | Designated as hedging instrument | Cash flow hedge | Minimum | LIBOR
Notional Disclosures
Derivative variable interest rate (as a percent)						0.10%		0%
Interest Rate Cap | Designated as hedging instrument | Cash flow hedge
Notional Disclosures
Notional amount					$ 100			$ 370
Derivative fixed interest rate (as a percent)					4.50%
Interest Rate Cap | Designated as hedging instrument | Cash flow hedge | Minimum | SOFR
Notional Disclosures
Derivative variable interest rate (as a percent)					3.982%
Interest Rate Cap | Designated as hedging instrument | Cash flow hedge | Maximum | SOFR
Notional Disclosures
Derivative variable interest rate (as a percent)					3.895%

Derivative Financial Instrume_4

Derivative Financial Instruments - Fair Value (Details) - USD ($) $ in Thousands	Sep. 28, 2024	Dec. 31, 2023
Other current assets | Foreign currency forward contracts | Derivatives not designated as hedging instruments:
Derivative Asset, Fair Value, Amount Not Offset Against Collateral
Derivative assets	$ 685	$ 1,186
Other current assets | Other derivative instruments | Derivatives not designated as hedging instruments:
Derivative Asset, Fair Value, Amount Not Offset Against Collateral
Derivative assets	36	38
Accrued expenses and other current liabilities | Interest rate contracts | Derivatives designated as hedging instruments:
Derivative Asset, Fair Value, Amount Not Offset Against Collateral
Derivative liabilities	342	0
Accrued expenses and other current liabilities | Foreign currency forward contracts | Derivatives not designated as hedging instruments:
Derivative Asset, Fair Value, Amount Not Offset Against Collateral
Derivative liabilities	1,828	2,975
Accrued expenses and other current liabilities | Other derivative instruments | Derivatives not designated as hedging instruments:
Derivative Asset, Fair Value, Amount Not Offset Against Collateral
Derivative liabilities	0	21
Deferred credits and other liabilities | Interest rate contracts | Derivatives designated as hedging instruments:
Derivative Asset, Fair Value, Amount Not Offset Against Collateral
Derivative liabilities	$ 519	$ 0

Fair Value of Financial Instr_3

Fair Value of Financial Instruments (Details) - USD ($) $ in Thousands	Sep. 28, 2024	Dec. 31, 2023
Assets:
Derivative Asset, Current, Statement of Financial Position [Extensible Enumeration]	Other current assets	Other current assets
Liabilities:
Derivative liabilities, recorded in accrued expenses and other current liabilities	$ 2,170	$ 2,996
Derivative Liability, Current, Statement of Financial Position [Extensible Enumeration]	Accrued expenses and other current liabilities (Note 8)	Accrued expenses and other current liabilities (Note 8)
Carrying Amount | Recurring
Assets:
Cash equivalents	$ 116,115	$ 71,139
Derivative assets, recorded in other current assets	721	1,224
Deferred compensation plan assets, recorded in other assets	4,963	2,098
Liabilities:
Debt, recorded in long-term debt and current maturities of long-term debt	1,219,800	1,232,780
Derivative liabilities, recorded in accrued expenses and other current liabilities	2,170	2,996
Derivative liability	519
Total Fair Value | Recurring
Assets:
Cash equivalents	116,115	71,139
Derivative assets, recorded in other current assets	721	1,224
Deferred compensation plan assets, recorded in other assets	4,963	2,098
Liabilities:
Debt, recorded in long-term debt and current maturities of long-term debt	1,217,502	1,209,961
Derivative liabilities, recorded in accrued expenses and other current liabilities	2,170	2,996
Derivative liability	519
Total Fair Value | Recurring | Level 1
Assets:
Cash equivalents	116,115	71,139
Derivative assets, recorded in other current assets	0	0
Deferred compensation plan assets, recorded in other assets	0	0
Liabilities:
Debt, recorded in long-term debt and current maturities of long-term debt	0	0
Derivative liabilities, recorded in accrued expenses and other current liabilities	0	0
Derivative liability	0
Total Fair Value | Recurring | Level 2
Assets:
Cash equivalents	0	0
Derivative assets, recorded in other current assets	721	1,224
Deferred compensation plan assets, recorded in other assets	4,963	2,098
Liabilities:
Debt, recorded in long-term debt and current maturities of long-term debt	1,217,502	1,209,961
Derivative liabilities, recorded in accrued expenses and other current liabilities	2,170	2,996
Derivative liability	519
Total Fair Value | Recurring | Level 3
Assets:
Cash equivalents	0	0
Derivative assets, recorded in other current assets	0	0
Deferred compensation plan assets, recorded in other assets	0	0
Liabilities:
Debt, recorded in long-term debt and current maturities of long-term debt	0	0
Derivative liabilities, recorded in accrued expenses and other current liabilities	0	$ 0
Derivative liability	$ 0

Commitments and Contingencies (

Commitments and Contingencies (Details) - USD ($) $ in Millions								1 Months Ended	9 Months Ended
	Jun. 20, 2022	Nov. 03, 2021	Feb. 18, 2021	Nov. 19, 2019	Apr. 12, 2019	Mar. 13, 2019	May 11, 2018	Feb. 28, 2018	Sep. 28, 2024	Dec. 31, 2023	Dec. 31, 2021
Loss Contingencies
Accrued self-insurance liability									$ 83.2	$ 89.2
Financing bonds and letters of credit									$ 71.6	$ 68.7
Environmental Loss Contingency, Current, Statement of Financial Position [Extensible Enumeration]									Accrued expenses and other current liabilities (Note 8)	Accrued expenses and other current liabilities (Note 8)
Environmental loss contingencies, current									$ 0	$ 0.5
Environmental Loss Contingency, Noncurrent, Statement of Financial Position [Extensible Enumeration]									Deferred credits and other liabilities	Deferred credits and other liabilities
Environmental loss contingencies, non-current									$ 11.5	$ 11.5
Preferred remedial alternatives totaling											$ 23.4
PaDEP
Loss Contingencies
Collateralized bond									1.4	$ 1.4
Minimum
Loss Contingencies
Environmental remedial feasibility alternative											11.8
Minimum | Domestic Product Liability
Loss Contingencies
Concentration risk, auto, employee and general liability									5
Minimum | Auto, General Liability, Personal Injury and Workers Compensation
Loss Contingencies
Concentration risk, auto, employee and general liability									3
Maximum
Loss Contingencies
Environmental remedial feasibility alternative											$ 33.4
Maximum | Domestic Product Liability
Loss Contingencies
Concentration risk, auto, employee and general liability									200
Maximum | Auto, General Liability, Personal Injury and Workers Compensation
Loss Contingencies
Concentration risk, auto, employee and general liability									$ 200
Steve and Sons
Loss Contingencies
Damages awarded to plaintiff			$ 36.5	$ 7.1		$ 36.5
Settlement proceeds awarded							$ 1.2
Damages sought			$ 139.4
Steve and Sons | Attorney Fees
Loss Contingencies
Damages sought					$ 28.4
Steve and Sons | Legal Cost
Loss Contingencies
Damages sought					$ 1.7
Direct Purchaser Action
Loss Contingencies
Damages sought	$ 10.5
Past Damages | Steve and Sons
Loss Contingencies
Damages awarded to plaintiff						9.9		$ 12.2
Future Damages | Steve and Sons
Loss Contingencies
Damages awarded to plaintiff						$ 139.4		$ 46.5
Loss contingency accrual, payments		$ 66.4

Supplemental Cash Flow Inform_3

Supplemental Cash Flow Information (Details) - USD ($) $ in Thousands	9 Months Ended
	Sep. 28, 2024	Sep. 30, 2023
Cash Operating Activities:
Operating leases	$ 35,397	$ 46,033
Interest payments on financing lease obligations	377	217
Cash paid for amounts included in the measurement of lease liabilities	35,774	46,250
Cash Investing Activities:
Purchases of securities for deferred compensation plan	(3,113)	(1,020)
Sale of securities for deferred compensation plan	0	127
Purchase of securities for deferred compensation plan	(3,113)	(893)
Cash received on notes receivable	31	0
Change in notes receivable	31	0
Non-cash Investing Activities:
Property, equipment, and intangibles purchased in accounts payable	13,378	5,422
Property, equipment, and intangibles purchased with debt	7,272	10,984
Customer accounts receivable converted to notes receivable	393	193
Consideration receivable from sale of business	2,000	0
Cash Financing Activities:
Borrowings on long-term debt	351,225	127,317
Payments of long-term debt	(371,536)	(672,755)
Payments of debt issuance and extinguishment costs, including underwriting fees	(5,284)	(3,908)
Change in long-term debt and payments of debt extinguishment costs	(25,595)	(549,346)
Cash paid for amounts included in the measurement of finance lease liabilities	1,865	1,351
Non-cash Financing Activities:
Prepaid insurance funded through short-term debt borrowings	0	16,628
Accounts payable converted to installment notes	5	176
Other Supplemental Cash Flow Information:
Cash taxes paid, net of refunds	29,575	41,988
Cash interest paid	$ 49,469	$ 53,442